{"content":"<li class=\"n-box-item date-title\" data-end=\"1550033999\" data-start=\"1549947600\" data-txt=\"Monday, December 23, 2019\">Tuesday, February 12, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3432491\" data-ts=\"1550012085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXY\" target=\"_blank\">OXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432491-occidental-petro-slips-despite-q4-beat-sees-production-gains-lower-capex\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Occidental Petro slips despite Q4 beat; sees production gains with lower capex</a></h4><ul><li>Occidental Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a>) <font color=\"red\">-1.6%</font> after-hours despite reporting better than expected <a href=\"https://seekingalpha.com/news/3432420-occidental-petroleum-beats-0_08-beats-revenue\" target=\"_blank\">Q4 earnings</a> and revenues, with record Q4 cash flow from operations before working capital of $1.9B.</li><li>OXY says Q4 total production rose 2.8% Y/Y to 700K boe/day, with Permian Basin production climbing 11% to 250K boe/day, at the high end of guidance, due to improved well performance and development activity.</li><li>At year-end 2018, OXY's preliminary worldwide proved reserves totaled 2.8B boe, compared to 2.6B boe at the end of 2017; proved reserves consisted of ~57% oil, 18% natural gas liquids and 25% gas.</li><li>OXY forecasts FY 2019 production growth of 9%-11%, with 30% Y/Y growth in Permian resources, while anticipated a 10% lower capital spending budget of $4.5B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432491\" data-linked=\"Occidental Petro slips despite Q4 beat; sees production gains with lower capex\" data-tweet=\"$OXY - Occidental Petro slips despite Q4 beat; sees production gains with lower capex https://seekingalpha.com/news/3432491-occidental-petro-slips-despite-q4-beat-sees-production-gains-lower-capex?source=tweet\" data-url=\"https://seekingalpha.com/news/3432491-occidental-petro-slips-despite-q4-beat-sees-production-gains-lower-capex\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432485\" data-ts=\"1550010795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLB\" target=\"_blank\">DLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432485-grpn-exel-and-uis-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GRPN, EXEL and UIS among after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/UIS' title='Unisys Corporation'>UIS</a> <font color=\"green\">+11.6%</font>. <a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a> <font color=\"green\">+6.9%</font>. <a href='https://seekingalpha.com/symbol/LSCC' title='Lattice Semiconductor Corporation'>LSCC</a> <font color=\"green\">+6.6%</font>. <a href='https://seekingalpha.com/symbol/IRTC' title='iRhythm Technologies'>IRTC</a> <font color=\"green\">+4.3%</font>. <a href='https://seekingalpha.com/symbol/JCOM' title='j2 Global, Inc.'>JCOM</a> <font color=\"green\">+3.4%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/AQ' title='Aquantia Corp.'>AQ</a> <font color=\"red\">-19.6%.</font> <a href='https://seekingalpha.com/symbol/QLYS' title='Qualys'>QLYS</a> <font color=\"red\">-14.4%</font>. <a href='https://seekingalpha.com/symbol/APEN' title='Apollo Endosurgery'>APEN</a> <font color=\"red\">-12.5%</font>.<a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a> <font color=\"red\">-12.4%</font>. <a href='https://seekingalpha.com/symbol/QUOT' title='Quotient Technology Inc.'>QUOT</a> <font color=\"red\">-10.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432485\" data-linked=\"GRPN, EXEL and UIS among after hour movers\" data-tweet=\"$DLB $UIS $EXEL - GRPN, EXEL and UIS among after hour movers https://seekingalpha.com/news/3432485-grpn-exel-and-uis-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3432485-grpn-exel-and-uis-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432480\" data-ts=\"1550010141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRPN\" target=\"_blank\">GRPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432480-grouponminus-14-after-profit-shortfall-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groupon -14% after profit shortfall in Q4</a></h4><ul>   <li>Groupon (NASDAQ:<a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a>) has tumbled after hours, <font color=\"red\">-13.8%</font>, after Q4 profits missed expectations despite an upside revenue surprise.</li>    <li>Revenues fell 8.4% Y/Y, less than expected, and gross profit dropped 5% to $366.1M.</li>    <li>Income from continuing operations dropped to $49.9M from $51.1M, and attributable net income &#40;GAAP&#41; fell to $46.2M from $47.7M.</li>    <li>Adjusted net income rose to $60M from $41.7M, and EBITDA dipped to $104.6M from $105.3M.</li>    <li>Global units sold dropped 8% to 50.5M (North America -13%, International +3%) amid lower traffic and a focus on long-term gross profit (leading to fewer units).</li>    <li>For the coming fiscal year, it's guiding to EBITDA of $270M, below expectations for $301.6M.</li>    <li>Cash and equivalents are at $841M and the company has an undrawn $250M revolving credit facility.</li>    <li><a href=\"https://investor.groupon.com/home/default.aspx\" target=\"_blank\">Conference call</a> to come tomorrow at 10 a.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432474-groupon-misses-0_03-beats-revenue\" target=\"_blank\">Groupon misses by $0.03, beats on revenue</a> (Feb. 12 2019)</li>    <li><a href=\"https://s22.q4cdn.com/731250486/files/doc_financials/quarterly/2018/q4/Q4-2018-Earnings-Release.pdf\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3432480\" data-linked=\"Groupon -14% after profit shortfall in Q4\" data-tweet=\"$GRPN - Groupon -14% after profit shortfall in Q4 https://seekingalpha.com/news/3432480-grouponminus-14-after-profit-shortfall-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3432480-grouponminus-14-after-profit-shortfall-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432473\" data-ts=\"1550009465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQ\" target=\"_blank\">AQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432473-aquantiaminus-22_5-q4-outlook-fall-well-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aquantia -22.5% as Q4, outlook fall well short</a></h4><ul>   <li>Aquantia (NYSE:<a href='https://seekingalpha.com/symbol/AQ' title='Aquantia Corp.'>AQ</a>) has tanked in after-hours trade, <font color=\"red\">down 22.5%</font>, after a heavy shortfall in its Q4 earnings and outlook.</li>    <li>Revenues grew 4.5% Y/Y but dropped 12% from the previous quarter to $29.1M.</li>    <li>Gross margin fell to 54% from the previous quarter's 58%.</li>    <li>\u201cWe are certainly disappointed in our fourth quarter results and outlook for the first quarter of 2019 due to the challenging data center end-market conditions,\u201d says CEO/Chairman Faraj Aalaei. \u201cNevertheless, we are encouraged by the growth prospects of our Enterprise Infrastructure and Access businesses in 2019.\u201d</li>    <li>Liquidity was $67.4M as of Dec. 31, nearly flat from the prior quarter's $67.3M.</li>    <li>For Q1, it's guiding to revenues of $19M-$21M, well short of consensus for $33.3M.</li>    <li>It also sees gross margin of 53.5%-55.5% and opex of $20.5M-$23M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432378-aquantia-misses-0_09-misses-revenue\" target=\"_blank\">Aquantia misses by $0.09, misses on revenue</a> (Feb. 12 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17410252-aquantia-announces-fourth-quarter-full-year-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3432473\" data-linked=\"Aquantia -22.5% as Q4, outlook fall well short\" data-tweet=\"$AQ - Aquantia -22.5% as Q4, outlook fall well short https://seekingalpha.com/news/3432473-aquantiaminus-22_5-q4-outlook-fall-well-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3432473-aquantiaminus-22_5-q4-outlook-fall-well-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432462\" data-ts=\"1550008720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432462-activision-to-lay-off-hundreds-shares-turn-higher-late\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activision to lay off hundreds; shares turn higher late</a></h4><ul>   <li>Activision Blizzard (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>), initially lower following <a href=\"https://seekingalpha.com/news/3432424-activision-minus-0_8-percent-amid-revenue-shortfalls\" target=\"_blank\">bookings disappointment</a> in its Q4 report, has turned <font color=\"green\">1.7% higher</font> during its conference call.</li>    <li>The company will <a href=\"https://variety.com/2019/gaming/news/activision-blizzard-layoffs-1203136982/\" target=\"_blank\">lay off about 8%</a> of its workforce -- about 775 employees -- as part of a restructuring where it will \"de-prioritize\" disappointing projects.</li>    <li>Employees will be focused on key franchises including <i>Call of Duty, Candy Crush Saga, Overwatch, Warcraft, Hearthstone</i> and <i>Diablo.</i></li>    <li>Activision will also invest more in live services, Battle.net, esports and advertising.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432462\" data-linked=\"Activision to lay off hundreds; shares turn higher late\" data-tweet=\"$ATVI - Activision to lay off hundreds; shares turn higher late https://seekingalpha.com/news/3432462-activision-to-lay-off-hundreds-shares-turn-higher-late?source=tweet\" data-url=\"https://seekingalpha.com/news/3432462-activision-to-lay-off-hundreds-shares-turn-higher-late\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432461\" data-ts=\"1550008709\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUBS\" target=\"_blank\">HUBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432461-hubspotminus-1_7-despite-q4-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HubSpot -1.7% despite Q4 beats</a></h4><ul><li>HubSpot (NYSE:<a href='https://seekingalpha.com/symbol/HUBS' title='HubSpot, Inc.'>HUBS</a>)<font color=\"red\"> drops 1.7%</font> after Q4 results that beat estimates with 35% Y/Y revenue growth but included in-line EPS guidance.</li><li>Q1 guidance has upside revenue from $146.5M to $147.5M (consensus: $145.95M) with EPS from $0.23 to $0.25 (consensus: $0.24).</li><li>FY19 guidance has upside revenue from $648M to $652M (consensus: $636.55M) with EPS from $1.08 to $1.16 (consensus: $1.12).</li><li>Q4 revenue breakdown: Subscription, $136.8M (consensus: $131.3M); Professional services and other, $7.2M (consensus: $6.2M).</li><li>Operating margin came in at 9.8% compared to the 8.7% consensus.</li><li><a href=\"https://seekingalpha.com/pr/17410283-hubspot-reports-q4-full-year-2018-results\" target=\"_blank\">Press release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3432389-hubspot-beats-0_07-beats-revenue\" target=\"_blank\">HubSpot beats by $0.07, beats on revenue</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432461\" data-linked=\"HubSpot -1.7% despite Q4 beats\" data-tweet=\"$HUBS - HubSpot -1.7% despite Q4 beats https://seekingalpha.com/news/3432461-hubspotminus-1_7-despite-q4-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3432461-hubspotminus-1_7-despite-q4-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432459\" data-ts=\"1550008413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCOM\" target=\"_blank\">JCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432459-j2-globalplus-3_4-after-record-q4-revenues-lead-to-profit-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J2 Global +3.4% after record Q4 revenues lead to profit beat</a></h4><ul>   <li>J2 Global (NASDAQ:<a href='https://seekingalpha.com/symbol/JCOM' title='j2 Global, Inc.'>JCOM</a>) is <font color=\"green\">up 3.4%</font> in postmarket trading after it topped high estimates with its adjusted profits amid posting record Q4 revenues, paced by heavy gains in digital media.</li>    <li>Net income ticked up to $50.6M on a GAAP basis from $49.9M.</li>    <li>EBITDA rose 8.7%, to $154.3M.</li>    <li>Net cash from operations rose 25.5% to $107.2M; free cash flow increased 27.2% to $95.8M. The company wrapped the quarter with $293.3M in liquidity.</li>    <li>Revenue by segment: Cloud Services, $148.1M (up 0.8%); Digital media, $198M (up 16.8%).</li>    <li>For the coming year, it's guiding to revenues of $1.29B-$1.33B (above consensus for $1.28B), EBITDA of $520M-$540 and EPS of $6.65-$6.95M (vs. consensus for $6.75).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432442-j2-global-beats-0_07-beats-revenue\" target=\"_blank\">j2 Global beats by $0.07, beats on revenue</a> (Feb. 12 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17410350-j2-global-reports-fourth-quarter-year-end-2018-results-provides-2019-outlook\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3432459\" data-linked=\"J2 Global +3.4% after record Q4 revenues lead to profit beat\" data-tweet=\"$JCOM - J2 Global +3.4% after record Q4 revenues lead to profit beat https://seekingalpha.com/news/3432459-j2-globalplus-3_4-after-record-q4-revenues-lead-to-profit-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3432459-j2-globalplus-3_4-after-record-q4-revenues-lead-to-profit-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432454\" data-ts=\"1550007866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRIP\" target=\"_blank\">TRIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432454-tripadvisorminus-5-on-mixed-q4-hotel-weakness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TripAdvisor -5% on mixed Q4 with Hotel weakness</a></h4><ul><li>TripAdvisor (NASDAQ:<a href='https://seekingalpha.com/symbol/TRIP' title='TripAdvisor Inc.'>TRIP</a>) <font color=\"red\">falls 5%</font> on Q4 results that beat revenue estimates but missed on EPS and Hotel performance metrics.</li><li>Hotel revenue: Total, $240M (consensus: $246.6M); Click-based and transaction, $139 (consensus: $142.1M); Display-based ad and subscription, $77M (consensus: $80.4M); Other, $24M (flat with consensus).</li><li>Non-hotel revenue was $106M, above the $97.2M consensus.</li><li>Average monthly unique hotel shoppers totaled 113M (consensus: 121M) and revenue per hotel shopper came in above the $0.39 consensus with $0.41.</li><li>FY guidance expects double-digit Adjusted EBIDA growth compared to the 11.5% analyst estimate.</li><li>Earnings call is scheduled for 8:30 AM ET tomorrow morning with a webcast available <a href=\"http://ir.tripadvisor.com/events-and-presentations\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17410276-tripadvisor-inc-earnings-press-release-available-companys-investor-relations-site\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432384-tripadvisor-misses-0_01-beats-revenue\" target=\"_blank\">TripAdvisor misses by $0.01, beats on revenue</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432454\" data-linked=\"TripAdvisor -5% on mixed Q4 with Hotel weakness\" data-tweet=\"$TRIP - TripAdvisor -5% on mixed Q4 with Hotel weakness https://seekingalpha.com/news/3432454-tripadvisorminus-5-on-mixed-q4-hotel-weakness?source=tweet\" data-url=\"https://seekingalpha.com/news/3432454-tripadvisorminus-5-on-mixed-q4-hotel-weakness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432441\" data-ts=\"1550007348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QUOT\" target=\"_blank\">QUOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432441-quotient-techminus-10-after-swing-to-q4-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quotient Tech -10% after swing to Q4 loss</a></h4><ul>   <li>Quotient Technology (NYSE:<a href='https://seekingalpha.com/symbol/QUOT' title='Quotient Technology Inc.'>QUOT</a>) has <font color=\"red\">slid 10.3%</font> after hours following a worse loss than expected in its Q4 earnings report, as rising costs outstripped sales gains.</li>    <li>Revenues grew 15% as expected, but the company swung to a loss of $4.5M on a GAAP basis vs. a year-ago profit of $4.2M.</li>    <li>EBITDA came to $16.5M, up from $13.9M.</li>    <li>The company reported transactions fell 11% to 869M.</li>    <li>Cash and equivalents were down to $302M from the prior-year $334.6M.</li>    <li>For Q1, it's guiding to revenue of $94M-$98M, and EBITDA of $6M-$8M. For the full year, it's expecting revenue of $460M-$470M and EBITDA of $66M-$71M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432371-quotient-technology-misses-0_03-revenue-line\" target=\"_blank\">Quotient Technology misses by $0.03,  revenue in-line</a> (Feb. 12 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17410239-quotient-technology-inc-reports-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3432441\" data-linked=\"Quotient Tech -10% after swing to Q4 loss\" data-tweet=\"$QUOT - Quotient Tech -10% after swing to Q4 loss https://seekingalpha.com/news/3432441-quotient-techminus-10-after-swing-to-q4-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3432441-quotient-techminus-10-after-swing-to-q4-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432434\" data-ts=\"1550007184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWLO\" target=\"_blank\">TWLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432434-twiliominus-2_8-on-mixed-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twilio -2.8% on mixed Q4</a></h4><ul><li>Twilio (NYSE:<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a>) shares <font color=\"red\">drop 2.8%</font> on Q4 results that beat revenue estimates with 77% Y/Y growth but met on EPS.</li><li>Q1 and FY19 guidance include the SendGrid acquisition (from February 1) and the consensus estimates don't so the two aren't comparable.</li><li>Q1 guidance expects revenue from $222M to $225M with EPS from $0 to $0.01. FY19 guidance has revenue of $1.065B to $1.077B and EPS from $0.08 to $0.11.</li><li>Q4 revenue breakdown: Base, $186.2M (consensus: $174.4M); Variable, $18.1M (consensus: $10.2M).</li><li>Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"https://investors.twilio.com/home/default.aspx\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17410301-twilio-announces-fourth-quarter-full-year-2018-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432401-twilio-eps-line-beats-revenue\" target=\"_blank\">Twilio EPS in-line, beats on revenue</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432434\" data-linked=\"Twilio -2.8% on mixed Q4\" data-tweet=\"$TWLO - Twilio -2.8% on mixed Q4 https://seekingalpha.com/news/3432434-twiliominus-2_8-on-mixed-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3432434-twiliominus-2_8-on-mixed-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432428\" data-ts=\"1550007099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXEL\" target=\"_blank\">EXEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432428-exelixis-to-launch-early-stage-study-of-kinase-inhibitor-xl092\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exelixis to launch early-stage study of kinase inhibitor XL092</a></h4><ul><li>Exelixis (NASDAQ:<a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a>) <a href=\"https://seekingalpha.com/pr/17410249-exelixis-initiate-phase-1-clinical-development-xl092-first-new-compound-enter-clinic\" target=\"_blank\">initiates </a>a Phase 1 clinical trial evaluating XL092, its first internally discovered compound to enter the clinic after it resumed drug discovery activities. The first phase will assess safety, tolerability and pharmacokinetics while the dose-escalation phase will generate preliminary efficacy data in patient with advanced solid tumors.</li><li>The company says XL092 is a next-generation oral tyrosine kinase inhibitor that targets kinases that play key roles in cancer proliferation and survival.</li><li>Shares are up <font color=\"green\">5%</font> after hours on its Q4 beat.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432428\" data-linked=\"Exelixis to launch early-stage study of kinase inhibitor XL092\" data-tweet=\"$EXEL - Exelixis to launch early-stage study of kinase inhibitor XL092 https://seekingalpha.com/news/3432428-exelixis-to-launch-early-stage-study-of-kinase-inhibitor-xl092?source=tweet\" data-url=\"https://seekingalpha.com/news/3432428-exelixis-to-launch-early-stage-study-of-kinase-inhibitor-xl092\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432417\" data-ts=\"1550006738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRTC\" target=\"_blank\">IRTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432417-irhythm-q4-sales-up-53-shares-ahead-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IRhythm Q4 sales up 53%; shares ahead 2% after hours</a></h4><ul><li>IRhythm (NASDAQ:<a href='https://seekingalpha.com/symbol/IRTC' title='iRhythm Technologies'>IRTC</a>) <a href=\"https://seekingalpha.com/pr/17410268-irhythm-technologies-announces-fourth-quarter-full-year-2018-financial-results-provides-full\" target=\"_blank\">Q4 results</a> ($M): Revenue: 43.2 (+53.2%).</li><li>Net loss: (14.7) (-32.4%); loss/share: (0.61) (-27.1%).</li><li>Sales headcount to reach 130 - 140 by year-end.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432382-irhythm-technologies-misses-0_16-beats-revenue\" target=\"_blank\">iRhythm Technologies misses by $0.16, beats on revenue</a> (Feb. 12 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432417\" data-linked=\"IRhythm Q4 sales up 53%; shares ahead 2% after hours\" data-tweet=\"$IRTC - IRhythm Q4 sales up 53%; shares ahead 2% after hours https://seekingalpha.com/news/3432417-irhythm-q4-sales-up-53-shares-ahead-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3432417-irhythm-q4-sales-up-53-shares-ahead-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432415\" data-ts=\"1550006651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DENN\" target=\"_blank\">DENN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432415-comparable-sales-up-2-dennys\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comparable sales up 2% at Denny&#39;s</a></h4><ul><li>Denny's (NASDAQ:<a href='https://seekingalpha.com/symbol/DENN' title='Denny&#39;s Corporation'>DENN</a>) reports in-line Q4 results off comparable sales growth of 2.1% at company-owned stores.</li><li>Company restaurant operating margin fell 20 bps to 16.2% of sales due chiefly to increases in minimum wages and third-party delivery costs.</li><li>Looking ahead, the company expects same-store sales growth at company and domestic franchised restaurants of between 0% and 2%.  35 to 45 new restaurant openings are anticipated. Restaurant operating margin is expected to fall between 15.0% and 16.5%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432375-dennys-eps-line-beats-revenue\" target=\"_blank\">Denny's EPS in-line, beats on revenue</a> (Feb. 12)</li><li>DENN <font color=\"green\">+0.11%</font> AH.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432415\" data-linked=\"Comparable sales up 2% at Denny&#39;s\" data-tweet=\"$DENN - Comparable sales up 2% at Denny&#39;s https://seekingalpha.com/news/3432415-comparable-sales-up-2-dennys?source=tweet\" data-url=\"https://seekingalpha.com/news/3432415-comparable-sales-up-2-dennys\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432409\" data-ts=\"1550006414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MUFG\" target=\"_blank\">MUFG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432409-akamaiplus-2-on-q4-beats-mufg-jv\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akamai +2% on Q4 beats, MUFG JV</a></h4><ul><li>Akamai Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a>) <font color=\"green\">gains 2%</font> after Q4 beats with 8% Y/Y revenue growth.</li><li>Revenue breakdown: Web Division, $385.3M (consensus: $385.1M); Media and Carrier Division, $328.1M (consensus: $318.6M).</li><li>Product revenue breakdown: Cloud Security Solutions, $184.8M (consensus: $180M); CDN and Other Solutions, $528.6M (consensus: $523M).</li><li>CFO change: SVP of Finance Ed McGowan will succeed the retiring Jim Benson as CFO, effective March 1.</li><li>Partnership expansion: AKAM and MUFG (NYSE:<a href='https://seekingalpha.com/symbol/MUFG' title='Mitsubishi UFJ Financial Group, Inc. Sponsored ADR'>MUFG</a>) <a href=\"https://seekingalpha.com/pr/17410204-akamai-mufg-announce-joint-venture-blockchain-based-online-payment-network\" target=\"_blank\">will form</a> a joint venture called the Global Open Network that will offer a new blockchain-based online payment network.</li><li>Earnings call is scheduled for 4:30 PM ET with a webcast available <a href=\"https://www.akamai.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17410222-akamai-reports-fourth-quarter-2018-full-year-2018-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432368-akamai-beats-0_07-beats-revenue\" target=\"_blank\">Akamai beats by $0.07, beats on revenue</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432409\" data-linked=\"Akamai +2% on Q4 beats, MUFG JV\" data-tweet=\"$MUFG $AKAM $MUFG - Akamai +2% on Q4 beats, MUFG JV https://seekingalpha.com/news/3432409-akamaiplus-2-on-q4-beats-mufg-jv?source=tweet\" data-url=\"https://seekingalpha.com/news/3432409-akamaiplus-2-on-q4-beats-mufg-jv\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432404\" data-ts=\"1550006280\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXEL\" target=\"_blank\">EXEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432404-exelixis-q4-beat-propels-shares-up-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exelixis Q4 beat propels shares, up 5% after hours</a></h4><ul><li>Exelixis (NASDAQ:<a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a>) <a href=\"https://seekingalpha.com/pr/17410269-exelixis-announces-fourth-quarter-full-year-2018-financial-results-provides-corporate-update\" target=\"_blank\">Q4 results</a> ($M): Revenues: 228.6 (+90.3%); cabozantinib sales: 176.2 (+84.1%).</li><li>Net income: 360.1 (+835.3%); non-GAAP net income: 116.0 (+201.3%); EPS: 1.15 (+858.3%); non-GAAP EPS: 0.37 (+208.3%).</li><li>Shares are up <font color=\"green\">5%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432377-exelixis-beats-0_14-beats-revenue\" target=\"_blank\">Exelixis beats by $0.14, beats on revenue</a> (Feb. 12 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432404\" data-linked=\"Exelixis Q4 beat propels shares, up 5% after hours\" data-tweet=\"$EXEL - Exelixis Q4 beat propels shares, up 5% after hours https://seekingalpha.com/news/3432404-exelixis-q4-beat-propels-shares-up-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3432404-exelixis-q4-beat-propels-shares-up-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432380\" data-ts=\"1550005878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNA\" target=\"_blank\">MRNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432380-modernas-combo-vaccine-shows-positive-action-in-early-stage-study-shares-up-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moderna&#39;s combo vaccine shows positive action in early-stage study; shares up 1% after hours</a></h4><ul><li>Moderna (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNA' title='Moderna, Inc.'>MRNA</a>) <a href=\"https://seekingalpha.com/pr/17410192-moderna-announces-positive-interim-phase-1-data-first-combination-vaccine-respiratory-viruses\" target=\"_blank\">announces </a>preliminary results from a Phase 1 clinical trial assessing combo vaccine mRNA-1653 in healthy volunteers. A single vaccination boosted serum neutralization titers against human metapneumovirus (hMPV) and parainfluenza type 3 virus (PIV3). One month post-administration, hMPV titers were about 6x from baseline while PIV3 titers were about 3x baseline.</li><li>Management will host a conference call today at 5:00 pm ET to discuss the results.</li><li>Shares are up <font color=\"green\">1%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432380\" data-linked=\"Moderna&#39;s combo vaccine shows positive action in early-stage study; shares up 1% after hours\" data-tweet=\"$MRNA - Moderna&#39;s combo vaccine shows positive action in early-stage study; shares up 1% after hours https://seekingalpha.com/news/3432380-modernas-combo-vaccine-shows-positive-action-in-early-stage-study-shares-up-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3432380-modernas-combo-vaccine-shows-positive-action-in-early-stage-study-shares-up-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432377\" data-ts=\"1550005762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXEL\" target=\"_blank\">EXEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432377-exelixis-beats-0_14-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exelixis beats by $0.14, beats on revenue</a></h4><ul><li>Exelixis (NASDAQ:<a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a>): Q4 Non-GAAP EPS of $0.37 <span style=\"color:green\">beats by $0.14</span>; GAAP EPS of $1.15 <span style=\"color:green\">beats by $0.92</span>.</li><li>Revenue of $228.6M (+90.4% Y/Y) <font color=\"green\">beats by $41.04M</font>.</li><li>Shares <font color=\"green\">+1.48%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17410269-exelixis-announces-fourth-quarter-full-year-2018-financial-results-provides-corporate-update\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3432377\" data-linked=\"Exelixis beats by $0.14, beats on revenue\" data-tweet=\"$EXEL - Exelixis beats by $0.14, beats on revenue https://seekingalpha.com/news/3432377-exelixis-beats-0_14-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3432377-exelixis-beats-0_14-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432362\" data-ts=\"1550005529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRAD\" target=\"_blank\">LRAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432362-lrad-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LRAD beats on revenue</a></h4><ul><li>LRAD (NASDAQ:<a href='https://seekingalpha.com/symbol/LRAD' title='LRAD Corp'>LRAD</a>): Q1 GAAP EPS of $0.03.</li><li>Revenue of $10.18M (+33.4% Y/Y) <font color=\"green\">beats by $2.17M</font>.</li><li>Shares <font color=\"green\">+1.27%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17410210-lrad-corporation-reports-record-fiscal-first-quarter-revenues\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3432362\" data-linked=\"LRAD beats on revenue\" data-tweet=\"$LRAD $GNSS - LRAD beats on revenue https://seekingalpha.com/news/3432362-lrad-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3432362-lrad-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432355\" data-ts=\"1550005401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGNX\" target=\"_blank\">MGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432355-macrogenics-launches-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MacroGenics launches stock offering</a></h4><ul><li>MacroGenics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a>) <a href=\"https://seekingalpha.com/pr/17410201-macrogenics-announces-proposed-public-offering-common-stock\" target=\"_blank\">commences </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432355\" data-linked=\"MacroGenics launches stock offering\" data-tweet=\"$MGNX - MacroGenics launches stock offering https://seekingalpha.com/news/3432355-macrogenics-launches-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3432355-macrogenics-launches-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432343\" data-ts=\"1550004622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALB\" target=\"_blank\">ALB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432343-livents-china-caution-clouds-lithium-industry-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Livent&#39;s China caution clouds lithium industry outlook</a></h4><ul><li>Lithium producers Albemarle (<a href='https://seekingalpha.com/symbol/ALB' title='Albemarle Corporation'>ALB</a> <font color='red'>-0.6%</font>), SQM (<a href='https://seekingalpha.com/symbol/SQM' title='Chemical & Mining Co. of Chile Inc.'>SQM</a> <font color='red'>-1.7%</font>) and Orocobre (<a href='https://seekingalpha.com/symbol/OROCF' title='Orocobre Ltd.'>OTCPK:OROCF</a> <font color='red'>-1.8%</font>) are lower after Livent (<a href='https://seekingalpha.com/symbol/LTHM' title='Livent'>LTHM</a> <font color='red'>-4.2%</font>) reports <a href=\"https://seekingalpha.com/news/3432215-livent-q4-earnings\" target=\"_blank\">disappointing quarterly results</a> and forecasts a <a href=\"https://www.reuters.com/article/us-livent-china-electric/livent-to-export-chinese-lithium-in-2019-due-to-subsidy-uncertainty-idUSKCN1Q11T2\" target=\"_blank\">drop in Chinese lithium sales</a> for the year because of uncertainty about the country\u2019s electric vehicle subsidies.</li><li>\"The Chinese consumers of lithium overextended themselves in 2018, built  more inventory than they were comfortable with and had a harder time  accessing credit,\" says LTHM CEO Paul Graves, who sees Chinese sales dropping below 20% of the company's total revenue in 2019 from 25% last year.</li><li>LTHM forecasts total 2019 lithium carbonate equivalent production of 22K-23K metric tons, which would be only a small increase from  last year despite rising electric vehicle sales globally.</li><li>Graves, who became CEO last year when Livent was spun off from FMC Corp.,  said Chinese customers had provided verbal commitments on price and volume late last year but backed away when the company went to sign the contracts, unwilling to sign deals for either one year or longer-term  unless the price was lowered.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432343\" data-linked=\"Livent&#39;s China caution clouds lithium industry outlook\" data-tweet=\"$ALB $SQM $LTHM - Livent&#39;s China caution clouds lithium industry outlook https://seekingalpha.com/news/3432343-livents-china-caution-clouds-lithium-industry-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3432343-livents-china-caution-clouds-lithium-industry-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432337\" data-ts=\"1550004190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432337-t-mobile-ceo-dont-and-wont-use-huawei-zte-gear\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile CEO: We don&#39;t and won&#39;t use Huawei or ZTE gear</a></h4><ul>   <li>As T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"green\">+1.7%</font>) CEO John Legere prepares for his <a href=\"https://seekingalpha.com/news/3430570-house-splits-hearings-t-mobile-sprint-deal\" target=\"_blank\">day in Congress</a> tomorrow, he plans to testify that the company resulting from a planned merger with Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"green\">+2.9%</font>) won't use gear from China's Huawei or ZTE (<a href='https://seekingalpha.com/symbol/ZTCOY' title='Zte Corp. ADR'>OTCPK:ZTCOY</a> <font color=\"green\">+2.4%</font>), two companies buffeted by U.S. security flak.</li>    <li>\u201cWe do not use Huawei or ZTE network equipment in any area of our network. Period,\" Legere's prepared testimony reads, according to Bloomberg. \"And we will never use it in our 5G network.\"</li>    <li>Legere and Sprint's Marcelo Claure are set to appear before the House Communications Subcommittee tomorrow, and then both head to the House Judiciary Antitrust Subcommittee on Thursday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432337\" data-linked=\"T-Mobile CEO: We don&#39;t and won&#39;t use Huawei or ZTE gear\" data-tweet=\"$ZTCOY $TMUS $S - T-Mobile CEO: We don&#39;t and won&#39;t use Huawei or ZTE gear https://seekingalpha.com/news/3432337-t-mobile-ceo-dont-and-wont-use-huawei-zte-gear?source=tweet\" data-url=\"https://seekingalpha.com/news/3432337-t-mobile-ceo-dont-and-wont-use-huawei-zte-gear\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432332\" data-ts=\"1550003062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432332-petrobras-upgraded-to-buy-ubs-on-confidence-in-new-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras upgraded to Buy at UBS on confidence in new CEO</a></h4><ul><li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color=\"green\">+4.8%</font>) pops as much as 5% after UBS <a href=\"https://www.barrons.com/articles/petrobras-stock-upgraded-on-hopes-for-production-growth-51549998046\" target=\"_blank\">upgrades shares to Buy</a> from Neutral, highlighting a favorable view of the leadership of CEO Roberto Castello Branco.</li><li>UBS believes the new CEO brings a new mindset which will help give the company a greater chance of achieving the two main pillars of its investment case - production growth and deleveraging.</li><li>If PBR divests more assets more quickly than anticipated, it could bring its net debt to EBITDA ratio below 1.5X, potentially \"unlocking significant equity value,\" writes UBS analyst Luis Carvalho.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432332\" data-linked=\"Petrobras upgraded to Buy at UBS on confidence in new CEO\" data-tweet=\"$PBR - Petrobras upgraded to Buy at UBS on confidence in new CEO https://seekingalpha.com/news/3432332-petrobras-upgraded-to-buy-ubs-on-confidence-in-new-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3432332-petrobras-upgraded-to-buy-ubs-on-confidence-in-new-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432327\" data-ts=\"1550001393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432327-vrns-ntgr-and-elli-among-notable-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VRNS, NTGR and ELLI among notable tech movers</a></h4><ul><li><strong>Gainers: </strong>Gridsum Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/GSUM' title='Gridsum Holding'>GSUM</a>) <font color=\"green\">+32%</font>. Ellie Mae (NYSEMKT:<a href='https://seekingalpha.com/symbol/ELLI' title='Ellie Mae, Inc.'>ELLI</a>) <font color=\"green\">+21%</font>. Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao'>QTT</a>) <font color=\"green\">+20%</font>. Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a>) <font color=\"green\">+14%</font>. Mimecast (NASDAQ:<a href='https://seekingalpha.com/symbol/MIME' title='Mimecast'>MIME</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>Varonis Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/VRNS' title='Varonis Systems Inc'>VRNS</a>) <font color=\"red\">-15%</font>. NETGEAR (NASDAQ:<a href='https://seekingalpha.com/symbol/NTGR' title='NETGEAR, Inc.'>NTGR</a>) <font color=\"red\">-15%</font>. Aethlon Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a>) <font color=\"red\">-14%</font>. Gilat Satellite Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/GILT' title='Gilat Satellite Networks Ltd.'>GILT</a>) <font color=\"red\">-10%</font>. SPI Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432327\" data-linked=\"VRNS, NTGR and ELLI among notable tech movers\" data-tweet=\"$GSUM $ELLI $QTT - VRNS, NTGR and ELLI among notable tech movers https://seekingalpha.com/news/3432327-vrns-ntgr-and-elli-among-notable-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3432327-vrns-ntgr-and-elli-among-notable-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432323\" data-ts=\"1550000518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432323-micronplus-4-ceo-expects-stronger-h2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron +4% as CEO expects stronger H2</a></h4><ul><li>Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) continues to see a stronger second half for 2019, according to CEO Sanjay Mehrotra's comments at the Goldman Sachs technology conference.</li><li>Mehrotra says DRAM end market demand remains healthy while content in smartphones continues to rise due to advanced features.</li><li>But Micron will be working through its higher inventory levels in the first half, and the company expects overall bit output growth to drop \"quite a bit\" this year.</li><li>Source: Bloomberg First Word.</li><li>Micron shares are<font color=\"green\"> </font><font color=\"green\">up 4.2%</font> to $40.18.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432323\" data-linked=\"Micron +4% as CEO expects stronger H2\" data-tweet=\"$MU - Micron +4% as CEO expects stronger H2 https://seekingalpha.com/news/3432323-micronplus-4-ceo-expects-stronger-h2?source=tweet\" data-url=\"https://seekingalpha.com/news/3432323-micronplus-4-ceo-expects-stronger-h2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>73&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432307\" data-ts=\"1549998945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432307-boeing-delivers-46-jets-vs-39-for-airbus-in-january\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing delivers 46 jets vs. 39 for Airbus in January</a></h4><ul><li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+1.6%</font>) says it <a href=\"https://www.reuters.com/article/us-boeing-deliveries/boeing-delivers-46-jets-in-january-idUSKCN1Q11XP?il=0\" target=\"_blank\">delivered 46 aircraft</a> in January, two more than a year ago, while European rival Airbus (<a href='https://seekingalpha.com/symbol/EADSF' title='Airbus SE'>OTCPK:EADSF</a>, <a href='https://seekingalpha.com/symbol/EADSY' title='Airbus SE ADR'>OTCPK:EADSY</a>) delivered 39 aircraft in January, up from 27 a year earlier.</li><li>Boeing tallied 43 net orders, including 18 for 787 Dreamliner jets as the company ramps up production rate for its wide-body aircraft to 14/month from 12 last year.</li><li>\"There continues to be some pent-up demand\" for the 787, says Jefferies analyst Sheila Kahyaoglu, adding that the order for the longest version of the 787 jets - the 787-10- is \"notable given it is the first since June 2017 when Singapore ordered 19 of the variant.\"</li><li>The remaining Boeing orders are for a military version of the best-selling 737 aircraft, the P-8 maritime patrol aircraft, as well as commercial sales to unidentified customers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432307\" data-linked=\"Boeing delivers 46 jets vs. 39 for Airbus in January\" data-tweet=\"$BA $EADSF $EADSY - Boeing delivers 46 jets vs. 39 for Airbus in January https://seekingalpha.com/news/3432307-boeing-delivers-46-jets-vs-39-for-airbus-in-january?source=tweet\" data-url=\"https://seekingalpha.com/news/3432307-boeing-delivers-46-jets-vs-39-for-airbus-in-january\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432305\" data-ts=\"1549998520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432305-fda-ad-com-backs-j-and-js-esketamine-nasal-spray-antidepressant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA Ad Com backs J&amp;J&#39;s esketamine nasal spray antidepressant</a></h4><ul><li>The <a href=\"https://seekingalpha.com/news/3431670-fda-ad-com-tomorrow-j-and-js-esketamine-nasal-spray\" target=\"_blank\">FDA advisory committees</a> voted 14 - 2 (1 abstain) in favor that Johnson &amp; Johnson's (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"green\">+1.5%</font>) Janssen Pharmaceuticals provided sufficient evidence to support the effectiveness of its esketamine nasal spray for treatment-resistant depression.</li><li><strong>Update</strong>: The vote was 15 - 2 in favor of the safety profile.</li><li><strong>Update</strong>: The vote was 14 - 2 (1 abstain) that the benefits outweigh the risks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432305\" data-linked=\"FDA Ad Com backs J&amp;J&#39;s esketamine nasal spray antidepressant\" data-tweet=\"$JNJ - FDA Ad Com backs J&amp;J&#39;s esketamine nasal spray antidepressant https://seekingalpha.com/news/3432305-fda-ad-com-backs-j-and-js-esketamine-nasal-spray-antidepressant?source=tweet\" data-url=\"https://seekingalpha.com/news/3432305-fda-ad-com-backs-j-and-js-esketamine-nasal-spray-antidepressant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432295\" data-ts=\"1549997973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432295-tronox-and-torchlight-energy-resources-among-energy-materials-gainers-bristow-group-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tronox and Torchlight Energy Resources among Energy/Materials gainers; Bristow Group and Callon Petroleum among losers</a></h4><ul><li><b>Gainers: </b>Tronox (NYSE:<a href='https://seekingalpha.com/symbol/TROX' title='Tronox Inc.'>TROX</a>) <font color=\"green\">+20%</font>. Torchlight Energy Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a>) <font color=\"green\">+12%</font>. PDC Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/PDCE' title='PDC Energy, Inc.'>PDCE</a>) <font color=\"green\">+9%</font>. ION Geophysical (NYSE:<a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a>) <font color=\"green\">+8%</font>. Legacy Reserves (NASDAQ:<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"red\">-35%</font>. Callon Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/CPE' title='Callon Petroleum Co.'>CPE</a>) <font color=\"red\">-8%</font>. Livent (NYSE:<a href='https://seekingalpha.com/symbol/LTHM' title='Livent'>LTHM</a>) <font color=\"red\">-6%</font>. Aceto (NASDAQ:<a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a>) <font color=\"red\">-6%</font>. Synalloy (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNL' title='Synalloy Corporation'>SYNL</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432295\" data-linked=\"Tronox and Torchlight Energy Resources among Energy/Materials gainers; Bristow Group and Callon Petroleum among losers\" data-tweet=\"$TROX $TRCH $PDCE - Tronox and Torchlight Energy Resources among Energy/Materials gainers; Bristow Group and Callon Petroleum among losers https://seekingalpha.com/news/3432295-tronox-and-torchlight-energy-resources-among-energy-materials-gainers-bristow-group-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3432295-tronox-and-torchlight-energy-resources-among-energy-materials-gainers-bristow-group-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432289\" data-ts=\"1549997448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLN\" target=\"_blank\">OLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432289-olin-gains-3_4-on-investor-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Olin gains 3.4% on investor day</a></h4><ul><li>Bulls are excited by the medium-term EBITDA target of $1.5B, and longer-term goal of $2B. The company in 2018 had $1.26B of EBITDA, and that produced free cash flow yield of 14%.</li><li><a href=\"https://s3.amazonaws.com/b2icontent.irpass.cc/1548/176550.pdf\" target=\"_blank\">Presentation slides are here</a></li><li><a href='https://seekingalpha.com/symbol/OLN' title='Olin Corporation'>OLN</a> <font color=\"green\">+3.4%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3432289\" data-linked=\"Olin gains 3.4% on investor day\" data-tweet=\"$OLN - Olin gains 3.4% on investor day https://seekingalpha.com/news/3432289-olin-gains-3_4-on-investor-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3432289-olin-gains-3_4-on-investor-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432279\" data-ts=\"1549996838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMF\" target=\"_blank\">OMF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432279-onemain-financialplus-15-on-new-dividend-q4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OneMain Financial +15% on new dividend, Q4 beat</a></h4><ul><li>OneMain Financial (NYSE:<a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a>) <font color=\"green\">surges 15%</font>, making it the biggest financial gainer, after announcing it <a href=\"https://seekingalpha.com/pr/17408528-onemain-holdings-inc-reports-fourth-quarter-2018-results\" target=\"_blank\">starting a 25-cent per share quarterly dividend</a>.</li><li>To be paid on March 15, 2019 to shareholders of record at the close of Feb. 26, 2019.</li><li><a href=\"https://seekingalpha.com/article/4240119-onemain-holdings-inc-2018-q4-results-earnings-call-slides\" target=\"_blank\">Priorities for 2019</a> includes stable yield, net charge-offs of less than 6.5%, consumer &amp; insurance ending net receivables up 5%-10%, and tangible leverage of 6.0x vs. 6.9x for 2018.</li><li>Reported Q4 consumer &amp; insurance adjusted EPS of $1.39, up from $1.31 in Q3 and $1.06 in Q4 2017.</li><li>Q4 GAAP EPS of $1.24 increased from $1.09 in Q3 and 29 cents in Q4 2017.</li><li>Book value per share of $27.97 at Dec. 31, 2018 increased from $26.80 at Sept. 30, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431910-onemain-holdings-beats-0_06-beats-revenue\" target=\"_blank\">OneMain Holdings beats by $0.06, beats on revenue</a> (Feb. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432279\" data-linked=\"OneMain Financial +15% on new dividend, Q4 beat\" data-tweet=\"$OMF - OneMain Financial +15% on new dividend, Q4 beat https://seekingalpha.com/news/3432279-onemain-financialplus-15-on-new-dividend-q4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3432279-onemain-financialplus-15-on-new-dividend-q4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432275\" data-ts=\"1549996702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRK\" target=\"_blank\">MRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432275-mercks-keytruda-trumps-opdivo-yervoy-in-first-line-kidney-cancer-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merck&#39;s Keytruda trumps Opdivo + Yervoy in first-line kidney cancer; shares up 3%</a></h4><ul><li>Merck (<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color=\"green\">+2.5%</font>) and Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-0.7%</font>) are going in opposite directions, albeit both on below-average volume. Investors appear to be reacting to late-stage data in first-line renal cell carcinoma &#40;RCC&#41;, the most common type of kidney cancer, that will be presented at the upcoming ASCO GU Cancers Symposium in San Francisco.</li><li><a href=\"https://seekingalpha.com/news/3432012-bristol-myers-opdivo-yervoy-shows-sustained-benefit-late-stage-rcc-study\" target=\"_blank\">Topline results</a> from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02853331?titles=keynote-426&amp;lead=merck&amp;phase=2&amp;rank=1\" target=\"_blank\">KEYNOTE-426</a> study evaluating Keytruda (pembrolizumab) plus Pfizer's (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"green\">+0.5%</font>) Inlyta (axitinib) in first-line RCC showed an overall response rate &#40;ORR&#41; of 59.3% with 47% less risk of death (hazard ratio = 0.53).</li><li><a href=\"https://seekingalpha.com/news/3432012-bristol-myers-opdivo-yervoy-shows-sustained-benefit-late-stage-rcc-study\" target=\"_blank\">Topline data</a> from the <a href=\"https://clinicaltrials.gov/ct2/show/NCT02231749?titles=checkmate-214&amp;lead=bristol-myers&amp;phase=2&amp;rank=1\" target=\"_blank\">CheckMate-214</a> trial evaluating Opdivo (nivolumab) plus low-dose Yervoy (ipilimumab) showed a 41% response rate  in the intent-to-treat population with a more modest 29% less risk of death (hazard ratio = 0.71).</li></ul><div class=\"tiny-share-widget\" data-id=\"3432275\" data-linked=\"Merck&#39;s Keytruda trumps Opdivo + Yervoy in first-line kidney cancer; shares up 3%\" data-tweet=\"$MRK $BMY $PFE - Merck&#39;s Keytruda trumps Opdivo + Yervoy in first-line kidney cancer; shares up 3% https://seekingalpha.com/news/3432275-mercks-keytruda-trumps-opdivo-yervoy-in-first-line-kidney-cancer-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3432275-mercks-keytruda-trumps-opdivo-yervoy-in-first-line-kidney-cancer-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432250\" data-ts=\"1549994903\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKTR\" target=\"_blank\">NKTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432250-bristol-myers-positive-rcc-data-pressures-nektar-down-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristol-Myers positive RCC data pressures Nektar, down 10%</a></h4><ul><li>Nektar Therapeutics (<a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color=\"red\">-9.6%</font>) slumps on almost 30% higher volume in apparent response to <a href=\"https://seekingalpha.com/news/3432012-bristol-myers-opdivo-yervoy-shows-sustained-benefit-late-stage-rcc-study\" target=\"_blank\">positive long-term results</a> from a Phase 3 clinical trial evaluating Bristol-Myers Squibb's (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-0.7%</font>) Opdivo + Yervoy in advanced/metastatic renal cell carcinoma &#40;RCC&#41;, the most common type of kidney cancer. Patients receiving the combo experienced significantly higher survival and response rates compared to Pfizer's Sutent.</li><li>This Friday, February 15, preliminary data from a Phase 1/2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02983045?titles=pivot-02&amp;lead=nektar&amp;rank=1\" target=\"_blank\">PIVOT-02</a>, evaluating bempegaldesleukin (NKTR-214), combined with Opdivo + Yervoy, in patients with advanced/metastatic solid tumors, including RCC, will be <a href=\"https://seekingalpha.com/pr/17408540-nektar-therapeutics-webcast-conference-call-urothelial-cancer-specialist-analysts-and\" target=\"_blank\">presented </a>at the ASCO GU Cancers Symposium in San Francisco.</li><li><strong>Update</strong>: <a href=\"https://seekingalpha.com/news/3432275-mercks-keytruda-trumps-opdivo-yervoy-first-line-kidney-cancer-shares-3-percent\" target=\"_blank\">Data </a>from a late-stage study of Merck's Keytruda plus Pfizer's Inlyta appear to be the main source of the downward pressure since the results topped BMY's Opdivo + Yervoy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432250\" data-linked=\"Bristol-Myers positive RCC data pressures Nektar, down 10%\" data-tweet=\"$NKTR $BMY - Bristol-Myers positive RCC data pressures Nektar, down 10% https://seekingalpha.com/news/3432250-bristol-myers-positive-rcc-data-pressures-nektar-down-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3432250-bristol-myers-positive-rcc-data-pressures-nektar-down-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432249\" data-ts=\"1549994744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432249-onemain-holdings-leads-financial-gainers-on-deck-capital-and-moneygram-international-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OneMain Holdings leads financial gainers; On Deck Capital and MoneyGram International among losers</a></h4><ul><li><b>Gainers: </b>OneMain Holdings (NYSE:<a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a>) <font color=\"green\">+15%</font>. Elevate Credit (NYSE:<a href='https://seekingalpha.com/symbol/ELVT' title='Elevate Credit'>ELVT</a>) <font color=\"green\">+14%</font>. Jones Lang LaSalle (NYSE:<a href='https://seekingalpha.com/symbol/JLL' title='Jones Lang Lasalle Inc.'>JLL</a>) <font color=\"green\">+14%</font>. Brighthouse Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/BHF' title='Brighthouse Financial, Inc.'>BHF</a>) <font color=\"green\">+14%</font>. Nomura Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NMR' title='Nomura Holdings, Inc.'>NMR</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Mmtec (<a href='https://seekingalpha.com/symbol/MTC' title='MMTEC Inc'>MTC</a>) <font color=\"red\">-13%</font>. CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a>) <font color=\"red\">-9%</font>. Omega Healthcare Investors (NYSE:<a href='https://seekingalpha.com/symbol/OHI' title='Omega Healthcare Investors, Inc'>OHI</a>) <font color=\"red\">-7%</font>. On Deck Capital (NYSE:<a href='https://seekingalpha.com/symbol/ONDK' title='OnDeck Capital'>ONDK</a>) <font color=\"red\">-7%</font>. MoneyGram International (NYSE:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432249\" data-linked=\"OneMain Holdings leads financial gainers; On Deck Capital and MoneyGram International among losers\" data-tweet=\"$OMF $ELVT $JLL - OneMain Holdings leads financial gainers; On Deck Capital and MoneyGram International among losers https://seekingalpha.com/news/3432249-onemain-holdings-leads-financial-gainers-on-deck-capital-and-moneygram-international-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3432249-onemain-holdings-leads-financial-gainers-on-deck-capital-and-moneygram-international-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432244\" data-ts=\"1549994218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENB\" target=\"_blank\">ENB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432244-minnesota-governor-to-continue-appeal-of-enbridge-line-3-project-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Minnesota governor to continue appeal of Enbridge Line 3 project approval</a></h4><ul><li>Minnesota's Gov. Walz says his administration will <a href=\"http://www.startribune.com/walz-will-continue-appeal-of-pipeline-project-approval/505716022/\" target=\"_blank\">continue to pursue an appeal</a> of the state's Public Utilities Commission approval of Enbridge's (<a href='https://seekingalpha.com/symbol/ENB' title='Enbridge Inc.'>ENB</a> <font color='red'>-1.5%</font>) plan to replace its aging Line 3 crude oil pipeline, siding with environmental and tribal groups.</li><li>The state PUC approved the project last summer, but then-Gov. Dayton's administration appealed that decision in December; the Minnesota Court of Appeals last week dismissed the appeals as premature and sent the dispute back to the PUC for further proceedings, forcing Walz to take a stand.</li><li>ENB wants to replace Line 3, which was built in the 1960s, because  it is increasingly subject to cracking and corrosion, so it can run at  only about half its original capacity.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432244\" data-linked=\"Minnesota governor to continue appeal of Enbridge Line 3 project approval\" data-tweet=\"$ENB - Minnesota governor to continue appeal of Enbridge Line 3 project approval https://seekingalpha.com/news/3432244-minnesota-governor-to-continue-appeal-of-enbridge-line-3-project-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/3432244-minnesota-governor-to-continue-appeal-of-enbridge-line-3-project-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432239\" data-ts=\"1549993772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432239-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong>CAS Medical Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CASM' title='CAS Medical Systems, Inc.'>CASM</a>) <font color=\"green\">+54%</font>. Pyxus International (NYSE:<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>) <font color=\"green\">+23%</font>. Gridsum Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/GSUM' title='Gridsum Holding'>GSUM</a>) <font color=\"green\">+22%</font>. Ellie Mae (NYSEMKT:<a href='https://seekingalpha.com/symbol/ELLI' title='Ellie Mae, Inc.'>ELLI</a>) <font color=\"green\">+21%</font>. Tronox (NYSE:<a href='https://seekingalpha.com/symbol/TROX' title='Tronox Inc.'>TROX</a>) <font color=\"green\">+19%</font>. Select Interior Concepts (NASDAQ:<a href='https://seekingalpha.com/symbol/SIC' title='Select Interior Concepts Inc'>SIC</a>) <font color=\"green\">+19%</font>. Insignia Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ISIG' title='Insignia Systems, Inc.'>ISIG</a>) <font color=\"green\">+18%</font>. Mimecast (NASDAQ:<a href='https://seekingalpha.com/symbol/MIME' title='Mimecast'>MIME</a>) <font color=\"green\">+17%</font>. ADMA Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics Inc'>ADMA</a>) <font color=\"green\">+16%</font>. OneMain Holdings (NYSE:<a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a>) <font color=\"green\">+16%</font>. <strong></strong></li> <li><strong>Losers: </strong>Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"red\">-35%</font>. PHI (NASDAQ:<a href='https://seekingalpha.com/symbol/PHIIK' title='PHI, Inc. - Non'>PHIIK</a>) <font color=\"red\">-26%</font>. DHX Media (NASDAQ:<a href='https://seekingalpha.com/symbol/DHXM' title='DHX Media Ltd Variable Voting'>DHXM</a>) <font color=\"red\">-17%</font>. TMSR Holding Company (NASDAQ:<a href='https://seekingalpha.com/symbol/TMSR' title='TMSR Holding Co., Ltd.'>TMSR</a>) <font color=\"red\">-17%</font>. Xeris Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XERS' title='Xeris Pharmaceuticals'>XERS</a>) <font color=\"red\">-17%</font>. Varonis Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/VRNS' title='Varonis Systems Inc'>VRNS</a>) <font color=\"red\">-15%</font>. Multi-Color (NASDAQ:<a href='https://seekingalpha.com/symbol/LABL' title='Multi-Color Corporation'>LABL</a>) <font color=\"red\">-14%</font>. Mmtec (<a href='https://seekingalpha.com/symbol/MTC' title='MMTEC Inc'>MTC</a>) <font color=\"red\">-13%</font>. NETGEAR (NASDAQ:<a href='https://seekingalpha.com/symbol/NTGR' title='NETGEAR, Inc.'>NTGR</a>) <font color=\"red\">-13%</font>. Adial Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADIL' title='ADial Pharmaceuticals, Inc'>ADIL</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432239\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CASM $PYX $GSUM - Midday Gainers / Losers https://seekingalpha.com/news/3432239-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3432239-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432236\" data-ts=\"1549992849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROX\" target=\"_blank\">TROX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432236-tronoxplus-19-ftc-joint-motion-indicates-progress-toward-cristal-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tronox +19% as FTC joint motion indicates progress toward Cristal deal</a></h4><ul><li>Tronox (<a href='https://seekingalpha.com/symbol/TROX' title='Tronox Inc.'>TROX</a> <font color=\"green\">+18.9%</font>) surges to its highest level in more than two months on news it <a href=\"https://seekingalpha.com/pr/17409273-tronox-ftc-file-joint-motion-delay-appeal-schedule\" target=\"_blank\">filed a joint motion</a> with the Federal Trade Commission requesting a delay of remaining appeals deadlines in the review of the company's proposed acquisition of Cristal's titanium dioxide business.</li><li>TORX says the filing reflects \"significant progress in advancing settlement discussions regarding a remedy transaction intended to resolve the Commission's competitive concerns with Tronox's pending acquisition.\"</li><li>The company has proposed to address the FTC's concerns through a  divestiture of all of Cristal's North American titanium dioxide business.</li><li>The joint filing suggests TROX and the FTC are making progress toward a compromise over the acquisition of the Saudi-based chemicals producer, which has been under regulatory scrutiny for two years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432236\" data-linked=\"Tronox +19% as FTC joint motion indicates progress toward Cristal deal\" data-tweet=\"$TROX - Tronox +19% as FTC joint motion indicates progress toward Cristal deal https://seekingalpha.com/news/3432236-tronoxplus-19-ftc-joint-motion-indicates-progress-toward-cristal-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3432236-tronoxplus-19-ftc-joint-motion-indicates-progress-toward-cristal-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432233\" data-ts=\"1549992391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432233-apparel-stocks-hitch-ride-under-armour\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apparel stocks hitch a ride with Under Armour</a></h4><ul><li>Apparel stocks are having a strong day after Under Armour (<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a> <font color='green'>+7.7%</font>) reports earnings and the U.S.-China trade news tilts favorably.</li><li>Notable gainers include Nike (<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='green'>+1.1%</font>), Lululemon (<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+4.3%</font>), Carter's (<a href='https://seekingalpha.com/symbol/CRI' title='Carter&#39;s, Inc.'>CRI</a> <font color='green'>+3.6%</font>), Hanesbransd (<a href='https://seekingalpha.com/symbol/HBI' title='Hanesbrands Inc.'>HBI</a> <font color='green'>+2.5%</font>), Wolverine World Wide (<a href='https://seekingalpha.com/symbol/WWW' title='Wolverine World Wide Inc.'>WWW</a> <font color='green'>+4.4%</font>), Fossil (<a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='green'>+4.2%</font>), Crocs (<a href='https://seekingalpha.com/symbol/CROX' title='Crocs, Inc.'>CROX</a> <font color='green'>+1.7%</font>), Caleres (<a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='green'>+1.8%</font>), Canada Goose (<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='green'>+2.1%</font>) and PVH (<a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a> <font color='green'>+1.5%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432120-armour-tightens-costs\" target=\"_blank\">Under Armour tightens up on costs</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432233\" data-linked=\"Apparel stocks hitch a ride with Under Armour\" data-tweet=\"$UAA $NKE $LULU - Apparel stocks hitch a ride with Under Armour https://seekingalpha.com/news/3432233-apparel-stocks-hitch-ride-under-armour?source=tweet\" data-url=\"https://seekingalpha.com/news/3432233-apparel-stocks-hitch-ride-under-armour\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432231\" data-ts=\"1549991736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCCO\" target=\"_blank\">SCCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432231-southern-copperminus-3-after-q4-miss-peru-plant-to-be-suspended-3minus-5-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southern Copper -3% after Q4 miss; Peru plant to be suspended 3-5 days</a></h4><ul><li>Southern Copper (<a href='https://seekingalpha.com/symbol/SCCO' title='Southern Copper Corporation'>SCCO</a> <font color='red'>-3.5%</font>) says it earned $293M in <a href=\"https://seekingalpha.com/news/3431978-southern-copper-misses-0_07-beats-revenue\" target=\"_blank\">Q4 net profit</a> compared to a $287M loss in the year-ago quarter, but shares are lower as the result still fell short of analyst expectations.</li><li>SCCO says its Q4 copper production rose 4% Y/Y to 226K tons while total copper sales rose 2.1%; for the full year, copper output edged 0.8% higher to 877K tons while sales fell 0.3%.</li><li>SCCO says a key plant it uses to produce copper in Peru will not fully restart for another 3-5 days while work is done on its tailings and railway infrastructure following heavy rains.</li><li>Peru's environmental regulator has been investigating a potential tailings spill at SCCO's Cuajone mine; the company says there is no tailings spill but its operations are being \"<a href=\"https://www.reuters.com/article/us-peru-southern-copper/southern-copper-says-peru-plant-to-be-partially-suspended-3-5-days-idUSKCN1Q01OB\" target=\"_blank\">seriously affected</a>\" by the recent intense rains in the country's southern copper belt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432231\" data-linked=\"Southern Copper -3% after Q4 miss; Peru plant to be suspended 3-5 days\" data-tweet=\"$SCCO - Southern Copper -3% after Q4 miss; Peru plant to be suspended 3-5 days https://seekingalpha.com/news/3432231-southern-copperminus-3-after-q4-miss-peru-plant-to-be-suspended-3minus-5-days?source=tweet\" data-url=\"https://seekingalpha.com/news/3432231-southern-copperminus-3-after-q4-miss-peru-plant-to-be-suspended-3minus-5-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432229\" data-ts=\"1549991577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILT\" target=\"_blank\">GILT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432229-gilat-satellite-slips-9-post-q4-results-provides-fy19-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilat Satellite slips 9% post Q4 results; provides FY19 guidance</a></h4><ul><li>Gilat Satellite Networks (<a href='https://seekingalpha.com/symbol/GILT' title='Gilat Satellite Networks Ltd.'>GILT</a> <font color=\"red\">-9.2%</font>) reported Q4 revenue decrease of 15.6% Y/Y to $69.73M. Segment revenues: Fixed Networks $35.42M (+2.1% Y/Y); Mobility Solutions $29,55M (-9.3% Y/Y); and Terrestrial Infrastructure Projects $4.75M (-69% Y/Y).</li><li>Q4 Gross margin <font color=\"green\">improved by 677 bps</font> to 37.3%; operating margin <font color=\"green\">improved by 395 bps</font> to 10.8%; and adj. operating margin<font color=\"green\"> improved by 280 bps</font> to 11.3%.</li><li>Adj. EBITDA was $10.53M (+17.3% Y/Y) and margin <font color=\"green\">improved by 427 bps </font>to 15.1%.</li><li>Q4 Expenses: R&amp;D $8.75M (+9.3% Y/Y); Selling &amp; Marketing $5.49M (-16.4% Y/Y); and G&amp;A $4.06M (-16% Y/Y).</li><li>Net cash provided by operating activities was $3.99M for the quarter, compared to cash used $20.89M a year ago.</li><li>Company has Cash, cash equivalents and restricted cash of $104.2M, as of December 31, 2018.</li><li>Company's Board of Directors expects to declare a cash dividend estimated at $25M (or ~$0.45 per share), subject to final approval of audited financial statements to be issued in March 2019.</li><li><strong>FY19 Guidance:</strong> Revenue $275M to $295M, GAAP operating income of $23M to $27M, and Adj. EBITDA $38M to $42M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432066-gilat-satellite-reports-q4-results\" target=\"_blank\">Gilat Satellite reports Q4 results</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432229\" data-linked=\"Gilat Satellite slips 9% post Q4 results; provides FY19 guidance\" data-tweet=\"$GILT - Gilat Satellite slips 9% post Q4 results; provides FY19 guidance https://seekingalpha.com/news/3432229-gilat-satellite-slips-9-post-q4-results-provides-fy19-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3432229-gilat-satellite-slips-9-post-q4-results-provides-fy19-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432228\" data-ts=\"1549991068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432228-ibm-opens-watson-ai-to-cloud-rivals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM opens Watson AI to cloud rivals</a></h4><ul><li>IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) <a href=\"https://seekingalpha.com/pr/17409897-ibm-watson-now-available-anywhere\" target=\"_blank\">announces</a> that Watson AI services will now work on any cloud platform including those of rivals Amazon and Microsoft.</li><li>Watson AI tools include Watson Assistant, which helps create conversational services like customer service bots, and Watson OpenScale for improved AI deployments.</li><li>IBM will use the open-source Kubernetes software to link Watson AI to other clouds.</li><li>IBM shares are <font color=\"green\">up 1.4%</font> to $135.92.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432228\" data-linked=\"IBM opens Watson AI to cloud rivals\" data-tweet=\"$IBM - IBM opens Watson AI to cloud rivals https://seekingalpha.com/news/3432228-ibm-opens-watson-ai-to-cloud-rivals?source=tweet\" data-url=\"https://seekingalpha.com/news/3432228-ibm-opens-watson-ai-to-cloud-rivals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432226\" data-ts=\"1549990934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432226-under-armour-and-coty-among-consumer-gainers-molson-coors-brewing-and-farmer-bros-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour and Coty among consumer gainers; Molson Coors Brewing and Farmer Bros. among losers</a></h4><ul><li><b>Gainers: </b>Pyxus International (NYSE:<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>) <font color=\"green\">+23%</font>. Coty (NYSE:<a href='https://seekingalpha.com/symbol/COTY' title='Coty Inc.'>COTY</a>) <font color=\"green\">+15%</font>. Under Armour (NYSE:<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>) <font color=\"green\">+7%</font>. Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) <font color=\"green\">+7%</font>. Energous (NASDAQ:<a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Tower International (NYSE:<a href='https://seekingalpha.com/symbol/TOWR' title='Tower International, Inc.'>TOWR</a>) <font color=\"red\">-12%</font>. Molson Coors Brewing (NYSE:<a href='https://seekingalpha.com/symbol/TAP' title='Molson Coors Brewing Company'>TAP</a>) <font color=\"red\">-9%</font>. Farmer Bros. (NASDAQ:<a href='https://seekingalpha.com/symbol/FARM' title='Farmer Brothers Company'>FARM</a>) <font color=\"red\">-7%</font>. Motorcar Parts of America (NASDAQ:<a href='https://seekingalpha.com/symbol/MPAA' title='Motorcar Parts of America, Inc.'>MPAA</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432226\" data-linked=\"Under Armour and Coty among consumer gainers; Molson Coors Brewing and Farmer Bros. among losers\" data-tweet=\"$PYX $COTY $UAA - Under Armour and Coty among consumer gainers; Molson Coors Brewing and Farmer Bros. among losers https://seekingalpha.com/news/3432226-under-armour-and-coty-among-consumer-gainers-molson-coors-brewing-and-farmer-bros-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3432226-under-armour-and-coty-among-consumer-gainers-molson-coors-brewing-and-farmer-bros-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432222\" data-ts=\"1549990457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALBKY\" target=\"_blank\">ALBKY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432222-alpha-bank-jumps-after-report-planning-bad-debt-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alpha Bank jumps after report it&#39;s planning bad debt sales</a></h4><ul><li>Alpha Bank (<a href='https://seekingalpha.com/symbol/ALBKY' title='Alpha Bank S.A. ADR'>OTCPK:ALBKY</a> <font color='green'>+3.2%</font>) surges after Bloomberg reports that the Greek lender is preparing two non-performing loan sales that could remove as much as EUR 3B ($3.4B) of bad debt from its balance sheet, according to two people familiar with the matter.</li><li>The timing and structure of the deals will depend on Greek government proposals to facilitate the disposal of bad debt. It's also waiting for clarity on personal bankruptcy reform legislation.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/ALBKF' title='Alpha Bank S.A.'>OTCPK:ALBKF</a>, <a href='https://seekingalpha.com/symbol/ALBQY' title='Alpha Bank S.A. ADR'>OTC:ALBQY</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3432222\" data-linked=\"Alpha Bank jumps after report it&#39;s planning bad debt sales\" data-tweet=\"$ALBKY $ALBKF $ALBQY - Alpha Bank jumps after report it&#39;s planning bad debt sales https://seekingalpha.com/news/3432222-alpha-bank-jumps-after-report-planning-bad-debt-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3432222-alpha-bank-jumps-after-report-planning-bad-debt-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432211\" data-ts=\"1549988911\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHXM\" target=\"_blank\">DHXM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432211-dhx-media-down-12-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DHX Media down 12% post Q2 results</a></h4><ul><li>DHX Media (<a href='https://seekingalpha.com/symbol/DHXM' title='DHX Media Ltd Variable Voting'>DHXM</a> <font color=\"red\">-12.7%</font>) reported Q2 revenue of $117M, a decrease of 4% Y/Y. Wildbrain revenue grew by 13% Y/Y to $19.9M and views increased 29% to 7B.</li><li>Q2 Gross margin <font color=\"red\">declined by 250 bps</font> to 41.7%, due to a lower volume of business in non-WildBrain distribution and the increasing share of revenue derived from WildBrain.</li><li>Adjusted EBITDA was $22M (-31.3% Y/Y), was reduced by $4.7M due to the sale of a minority stake in Peanuts to Sony; and margin <font color=\"red\">declined by 745 bps</font> to 18.8%.</li><li>Company generated positive operating cash flow of $11.6M, compared to $1.1M outflow a year ago; and paid down crdit facility by $9.5M during the quarter.</li><li>Company signed its largest multi-year content partnership agreement end of Q2, which is expected to begin generating earnings this year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432014-dhx-media-reports-q2-results\" target=\"_blank\">DHX Media reports Q2 results</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432211\" data-linked=\"DHX Media down 12% post Q2 results\" data-tweet=\"$DHXM - DHX Media down 12% post Q2 results https://seekingalpha.com/news/3432211-dhx-media-down-12-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3432211-dhx-media-down-12-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432208\" data-ts=\"1549988528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IHI\" target=\"_blank\">IHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432208-medical-devices-maintain-strength-ihi-up-11-ytd\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medical devices maintain strength, IHI up 11% ytd</a></h4><ul><li>Medical devices, normally a rather staid group compared to the fireworks in biotechs, continue to hold their own. The iShares U.S. Medical Devices ETF (<a href='https://seekingalpha.com/symbol/IHI' title='iShares U.S. Medical Devices ETF'>IHI</a> <font color=\"green\">+1.3%</font>) is up almost <font color=\"green\">11%</font> ytd.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corp'>EW</a> <font color=\"green\">+2%</font>)(<a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a> <font color=\"green\">+0.5%</font>)(<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a> <font color=\"green\">+1.7%</font>)(<a href='https://seekingalpha.com/symbol/ANGO' title='AngioDynamics, Inc.'>ANGO</a> <font color=\"green\">+1%</font>)(<a href='https://seekingalpha.com/symbol/BAX' title='Baxter International Inc'>BAX</a> <font color=\"green\">+0.9%</font>)(<a href='https://seekingalpha.com/symbol/BIO' title='Bio-Rad Laboratories, Inc.'>BIO</a> <font color=\"green\">+2.4%</font>)(<a href='https://seekingalpha.com/symbol/BSX' title='Boston Scientific Corporation'>BSX</a> <font color=\"green\">+2.2%</font>)(<a href='https://seekingalpha.com/symbol/CNMD' title='CONMED Corporation'>CNMD</a> <font color=\"green\">+0.8%</font>)(<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a> <font color=\"green\">+2.4%</font>)(<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color=\"green\">+8.7%</font>)(<a href='https://seekingalpha.com/symbol/PODD' title='Insulet Corporation'>PODD</a> <font color=\"green\">+2.6%</font>)(<a href='https://seekingalpha.com/symbol/OSUR' title='OraSure Technologies, Inc.'>OSUR</a> <font color=\"green\">+2.7%</font>)(<a href='https://seekingalpha.com/symbol/RMD' title='ResMed Inc.'>RMD</a> <font color=\"green\">+0.6%</font>)(<a href='https://seekingalpha.com/symbol/SNN' title='Smith & Nephew plc'>SNN</a>)(<a href='https://seekingalpha.com/symbol/SYK' title='Stryker Corporation'>SYK</a> <font color=\"green\">+0.6%</font>)(<a href='https://seekingalpha.com/symbol/WMGI' title='Wright Medical Group, Inc.'>WMGI</a> <font color=\"green\">+0.9%</font>)(<a href='https://seekingalpha.com/symbol/ZBH' title='Zimmer Biomet Holdings, Inc.'>ZBH</a> <font color=\"green\">+0.9%</font>)(<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a> <font color=\"green\">+2%</font>)(<a href='https://seekingalpha.com/symbol/NVRO' title='Nevro'>NVRO</a> <font color=\"green\">+2%</font>)(<a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a> <font color=\"green\">+1%</font>)(<a href='https://seekingalpha.com/symbol/CSII' title='Cardiovascular Systems, Inc.'>CSII</a> <font color=\"green\">+1.7%</font>)(<a href='https://seekingalpha.com/symbol/CEMI' title='Chembio Diagnostics, Inc.'>CEMI</a> <font color=\"green\">+2.3%</font>)(<a href='https://seekingalpha.com/symbol/GMED' title='Globus Medical'>GMED</a> <font color=\"green\">+1.3%</font>)(<a href='https://seekingalpha.com/symbol/XHE' title='SPDR S&P Health Care Equipment ETF'>XHE</a> <font color=\"green\">+1.2%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432208\" data-linked=\"Medical devices maintain strength, IHI up 11% ytd\" data-tweet=\"$IHI $EW $MDT - Medical devices maintain strength, IHI up 11% ytd https://seekingalpha.com/news/3432208-medical-devices-maintain-strength-ihi-up-11-ytd?source=tweet\" data-url=\"https://seekingalpha.com/news/3432208-medical-devices-maintain-strength-ihi-up-11-ytd\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432203\" data-ts=\"1549987743\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432203-mattel-now-up-36-since-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattel now up 36% since earnings</a></h4><ul> <li>Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) is up another <font color=\"green\">6.95%</font> to push shares to their highest level since last June.</li> <li>The post-earnings rally for Mattel is now +36% and counting.</li> <li>During Mattel's <a href=\"https://seekingalpha.com/article/4239276-mattel-inc-2018-q4-results-earnings-call-slides\" target=\"_blank\">earnings presentation</a>, management cited the long-term potential of unlocking intellectual property upside, while also guiding for run-rate cost savings of $650M for this year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431042-mattel-pops-posting-unexpected-profit\" target=\"_blank\">Mattel pops after posting unexpected profit</a> (Feb. 7)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431399-toy-story-mattel-outperforms-hasbro\" target=\"_blank\">Toy story: Mattel outperforms Hasbro</a> (Feb. 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432203\" data-linked=\"Mattel now up 36% since earnings\" data-tweet=\"$MAT - Mattel now up 36% since earnings https://seekingalpha.com/news/3432203-mattel-now-up-36-since-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3432203-mattel-now-up-36-since-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432201\" data-ts=\"1549987664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432201-mylan-launches-generic-version-of-glaxos-advair-diskus-70-discount\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan launches generic version of Glaxo&#39;s Advair Diskus at 70% discount</a></h4><ul><li>Mylan N.V. (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color=\"green\">+1.6%</font>) <a href=\"https://seekingalpha.com/pr/17409731-mylan-launches-wixela-inhub-fluticasone-propionate-salmeterol-inhalation-powder-usp-first\" target=\"_blank\">announces </a>the U.S. commercial launch of Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), its generic version of GlaxoSmithKline's (<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color=\"green\">+0.4%</font>) asthma and COPD med Advair Diskus.</li><li>The company says its wholesale cost is 70% less that Glaxo's branded product and 67% less than its authorized generic.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432201\" data-linked=\"Mylan launches generic version of Glaxo&#39;s Advair Diskus at 70% discount\" data-tweet=\"$MYL $GSK - Mylan launches generic version of Glaxo&#39;s Advair Diskus at 70% discount https://seekingalpha.com/news/3432201-mylan-launches-generic-version-of-glaxos-advair-diskus-70-discount?source=tweet\" data-url=\"https://seekingalpha.com/news/3432201-mylan-launches-generic-version-of-glaxos-advair-diskus-70-discount\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432199\" data-ts=\"1549987422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432199-stellar-biotechnologies-and-alphatec-holdings-among-healthcare-gainers-nektar-therapeutics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stellar Biotechnologies and Alphatec Holdings among healthcare gainers; Nektar Therapeutics and Molina Healthcare among losers</a></h4><ul><li><b>Gainers: </b>CAS Medical Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CASM' title='CAS Medical Systems, Inc.'>CASM</a>) <font color=\"green\">+54%</font>. ADMA Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics Inc'>ADMA</a>) <font color=\"green\">+19%</font>. Stellar Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a>) <font color=\"green\">+11%</font>. BioXcel Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BTAI' title='BioXcel Therapeutics'>BTAI</a>) <font color=\"green\">+11%</font>. Alphatec Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a>) <font color=\"green\">+10%</font>.</li><li><b>Losers: </b>Xeris Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XERS' title='Xeris Pharmaceuticals'>XERS</a>) <font color=\"red\">-17%</font>. Adial Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADIL' title='ADial Pharmaceuticals, Inc'>ADIL</a>) <font color=\"red\">-15%</font>. Nektar Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a>) <font color=\"red\">-10%</font>. Nemaura Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/NMRD' title='Nemaura Medical, Inc.'>NMRD</a>) <font color=\"red\">-9%</font>. Molina Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432199\" data-linked=\"Stellar Biotechnologies and Alphatec Holdings among healthcare gainers; Nektar Therapeutics and Molina Healthcare among losers\" data-tweet=\"$CASM $ADMA $EDSA - Stellar Biotechnologies and Alphatec Holdings among healthcare gainers; Nektar Therapeutics and Molina Healthcare among losers https://seekingalpha.com/news/3432199-stellar-biotechnologies-and-alphatec-holdings-among-healthcare-gainers-nektar-therapeutics?source=tweet\" data-url=\"https://seekingalpha.com/news/3432199-stellar-biotechnologies-and-alphatec-holdings-among-healthcare-gainers-nektar-therapeutics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432194\" data-ts=\"1549987174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDCM\" target=\"_blank\">RDCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432194-radcomminus-7-on-mixed-q4-analyst-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Radcom -7% on mixed Q4, analyst downgrade</a></h4><ul><li>Needham downgrades Radcom (NASDAQ:<a href='https://seekingalpha.com/symbol/RDCM' title='Radcom Ltd.'>RDCM</a>) from Buy to Hold after this morning's Q4 report beat revenue estimates but missed on EPS.</li><li>Key Radcom management quote from the report: \"Although our results were affected by a slower than expected pace of NFV transformations, and while market conditions continue to affect our visibility into when operators will implement their NFV and 5G plans, we remain confident in the future of NFV and 5G and in our technological leadership, our solutions and strong industry recognition.\"</li><li><a href=\"https://seekingalpha.com/pr/17408995-radcom-reports-fourth-quarter-full-year-2018-results\" target=\"_blank\">Press release</a>.</li><li>RDCM shares are<font color=\"red\"> down 6.8%</font> to $7.50.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432053-radcom-misses-0_01-beats-revenue\" target=\"_blank\">Radcom misses by $0.01, beats on revenue</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432194\" data-linked=\"Radcom -7% on mixed Q4, analyst downgrade\" data-tweet=\"$RDCM - Radcom -7% on mixed Q4, analyst downgrade https://seekingalpha.com/news/3432194-radcomminus-7-on-mixed-q4-analyst-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3432194-radcomminus-7-on-mixed-q4-analyst-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432191\" data-ts=\"1549986711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TME\" target=\"_blank\">TME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432191-tencent-musicplus-3_5-macquarie-starts-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tencent Music +3.5% as Macquarie starts at Outperform</a></h4><ul>   <li>Tencent Music Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/TME' title='Tencent Music Entertainment Group'>TME</a>) is <font color=\"green\">up 3.5%</font> after Macquarie launched coverage at Outperform.</li>    <li>The firm's set a price target of $19.50, implying 25% further upside after today's early move up.</li>    <li>After a little time in the weeds since its mid-December debut, <a href='https://seekingalpha.com/symbol/TME' title='Tencent Music Entertainment Group'>TME</a> has spent most of the past month above its IPO price of $13. Shares are at $15.55 currently.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432191\" data-linked=\"Tencent Music +3.5% as Macquarie starts at Outperform\" data-tweet=\"$TME - Tencent Music +3.5% as Macquarie starts at Outperform https://seekingalpha.com/news/3432191-tencent-musicplus-3_5-macquarie-starts-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3432191-tencent-musicplus-3_5-macquarie-starts-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432188\" data-ts=\"1549986287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMRK\" target=\"_blank\">NMRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432188-newmark-rises-after-small-q4-beat-issues-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newmark rises after small Q4 beat, issues guidance</a></h4><ul><li>Newmark Group (<a href='https://seekingalpha.com/symbol/NMRK' title='Newmark Group, Inc.'>NMRK</a> <font color='green'>+0.9%</font>)<a href=\"http://www.ngkf.com/Uploads/FileManager/In%20the%20News/4Q18%20NMRK%20Release%20final.pdf\" target=\"_blank\"> issues 2019 guidance </a>for adjusted EPS of $1.55-$1.65 and revenue of $2.2B-$2.3B.</li><li>Revenue guidance compares with average analyst estimate of $2.19B; midpoint of adjusted EPS range of $1.60 trails the consensus estimate of $1.62.</li><li><a href=\"https://seekingalpha.com/pr/17409176-newmark-group-reports-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4 adjusted EPS</a> of 45 cents, exceeding consensus of 44 cents, increased from 30 cents in the year-ago period.</li><li>Q4 revenue of $631.7M, beating consensus by $40.1M, increased 37% from $460.6M a year ago. By segment:</li></ul><ol><li>Leasing and other commissions jumped 48% Y/Y to $276.0M.</li><li>Capital markets increased 19% to $150.4M</li><li>Management services, servicing fees, and other surged 47% to $155.8M</li><li>Gains from mortgage banking activities/origination, net, of $49.5M, up 19%.</li></ol><ul><li>Previously: <a href=\"https://seekingalpha.com/news/3432081-newmark-group-beats-0_01-beats-revenue\" target=\"_blank\">Newmark Group beats by $0.01, beats on revenue</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432188\" data-linked=\"Newmark rises after small Q4 beat, issues guidance\" data-tweet=\"$NMRK - Newmark rises after small Q4 beat, issues guidance https://seekingalpha.com/news/3432188-newmark-rises-after-small-q4-beat-issues-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3432188-newmark-rises-after-small-q4-beat-issues-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432187\" data-ts=\"1549985926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INGN\" target=\"_blank\">INGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432187-inogen-slips-4-on-bearish-citron-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inogen slips 4% on bearish Citron report</a></h4><ul><li>Following <a href=\"https://seekingalpha.com/news/3431371-inogen-slides-7-percent-muddy-waters-takes-aim\" target=\"_blank\">Muddy Waters</a>' lead, Citron Research issues its own <a href=\"https://citronresearch.com/citron-exposes-elder-abuse-within-inogens-sale-tactics-price-target-46/\" target=\"_blank\">bearish outlook</a> on Inogen (<a href='https://seekingalpha.com/symbol/INGN' title='Inogen, Inc'>INGN</a> <font color=\"red\">-4.2%</font>), exemplified with its $46 (67% downside risk) fair value target.</li><li>Citron cites the company's \"dirty\" reseller network and <a href=\"https://citronresearch.com/wp-content/uploads/2019/02/Citron-Exposes-Elder-Abuse-Within-Inogen%E2%80%99s-Sale-Tactics.pdf\" target=\"_blank\">systematic abuse</a> of elders by the company and resellers through their deceptive sales practices, adding that less than 10% of its sales come from Medicare despite the 75+ average age of its customers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432187\" data-linked=\"Inogen slips 4% on bearish Citron report\" data-tweet=\"$INGN - Inogen slips 4% on bearish Citron report https://seekingalpha.com/news/3432187-inogen-slips-4-on-bearish-citron-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3432187-inogen-slips-4-on-bearish-citron-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432184\" data-ts=\"1549985665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432184-starbucks-runs-to-all-time-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starbucks runs to all-time high</a></h4><ul> <li>Starbucks (<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a> <font color=\"green\">+0.3%</font>) trades at an all-time high as investors dismiss any concerns that the presidential run of Howard Schultz or the rapid growth of Luckin Coffee in China will pressure shares.</li> <li>Long-term growth expectations on Starbucks seem to be overriding the warnings from some doubters that SBUX's valuation is stretched at $70. \"The company should be able to deliver double digit EPS growth over the next several years and a low-to mid-teens total shareholder return driven by solid unit growth and top-line growth coupled with material share repurchases,\" reads the BAML bull case.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3432184\" data-linked=\"Starbucks runs to all-time high\" data-tweet=\"$SBUX - Starbucks runs to all-time high https://seekingalpha.com/news/3432184-starbucks-runs-to-all-time-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3432184-starbucks-runs-to-all-time-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432180\" data-ts=\"1549985429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDSO\" target=\"_blank\">MDSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432180-medidata-solutionsminus-1-on-mixed-q4-downside-fy-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medidata Solutions -1% on mixed Q4, downside FY guide</a></h4><ul><li>Medidata Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MDSO' title='Medidata Solutions, Inc.'>MDSO</a>) <font color=\"red\">drops 1.1%</font> after reporting Q4 results that beat EPS estimates but missed on revenue. Downside FY19 guidance has revenue from $734M to $746M compared to the $749.67 consensus.</li><li>Revenue breakdown: Subscription, $141.3M (consensus: $143M); Professional Services, $25.9M (consensus: $24.8M).</li><li><a href=\"https://seekingalpha.com/pr/17408810-medidata-reports-fourth-quarter-2018-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431989-medidata-solutions-beats-0_08-misses-revenue\" target=\"_blank\">Medidata Solutions beats by $0.08, misses on revenue</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432180\" data-linked=\"Medidata Solutions -1% on mixed Q4, downside FY guide\" data-tweet=\"$MDSO - Medidata Solutions -1% on mixed Q4, downside FY guide https://seekingalpha.com/news/3432180-medidata-solutionsminus-1-on-mixed-q4-downside-fy-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3432180-medidata-solutionsminus-1-on-mixed-q4-downside-fy-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432177\" data-ts=\"1549984896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RLGT\" target=\"_blank\">RLGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432177-radiant-logistics-up-8-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Radiant Logistics up 8% post Q2 results</a></h4><ul><li>Radiant Logistics (<a href='https://seekingalpha.com/symbol/RLGT' title='Radiant Logistics, Inc.'>RLGT</a> <font color=\"green\">+8.9%</font>) reported Q2 revenue growth of 26.2% Y/Y to $260.94M, and net revenue of $63.96M (+35% Y/Y).</li><li>U.S. revenues $231.8M (+29.1% Y/Y); and net revenue of $55.5M (+36% Y/Y), where Transportation net revenues were $54.4M (+35.3% Y/Y) and Value added services net revenues were $1.1M (+83.3% Y/Y).</li><li>Canada revenues $29.3M (+6.2% Y/Y); and net revenue of $8.5M (+28.8% Y/Y), where Transportation net revenues were $5.1M (+24.4% Y/Y) and Value added services net revenues were $3.4M (+36% Y/Y).</li><li>Q2 Net revenue margin i<font color=\"green\">mproved by 160 bps</font> to 24.5%; and operating margin <font color=\"green\">improved by 203 bps </font>to 3.4%.</li><li>Adj. EBITDA was $12.5M (+76.1% Y/Y) and margin <font color=\"green\">improved by 440 bps</font> to 19.5% (expressed as a function of net revenue).</li><li>SG&amp;A expenses were $7.52M (+18.4% Y/Y).</li><li>Company generated cash from operations of $16.4M for the six months ended December 31, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431830-radiant-logistics-beats-0_06\" target=\"_blank\">Radiant Logistics beats by $0.06</a> (Feb. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432177\" data-linked=\"Radiant Logistics up 8% post Q2 results\" data-tweet=\"$RLGT - Radiant Logistics up 8% post Q2 results https://seekingalpha.com/news/3432177-radiant-logistics-up-8-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3432177-radiant-logistics-up-8-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432174\" data-ts=\"1549984501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAT\" target=\"_blank\">NAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432174-nordic-american-tankerplus-4-on-new-five-year-306m-credit-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordic American Tanker +4% on new five-year, $306M credit deal</a></h4><ul><li>Nordic American Tanker (<a href='https://seekingalpha.com/symbol/NAT' title='Nordic American Tankers Limited'>NAT</a> <font color=\"green\">+4%</font>) pops at the open after announcing it has entered into a <a href=\"https://seekingalpha.com/pr/17409614-nordic-american-tankers-ltd-nyse-nat-new-capital-structure-major-breakthrough-securing\" target=\"_blank\">five-year, $306M senior secured credit agreement</a>.</li><li>NAT says the new credit will see the effective interest reduced from the previous revolving credit facility and lower than indicated for the secured bond it considered in 2018 as well as the backstop facility that was cancelled in Q3 2018.</li><li>NAT says the financing will \"continue to secure a competitive cash breakeven rate [and] more importantly, the new loan allows... greater flexibility  in setting dividend payments.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3432174\" data-linked=\"Nordic American Tanker +4% on new five-year, $306M credit deal\" data-tweet=\"$NAT - Nordic American Tanker +4% on new five-year, $306M credit deal https://seekingalpha.com/news/3432174-nordic-american-tankerplus-4-on-new-five-year-306m-credit-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3432174-nordic-american-tankerplus-4-on-new-five-year-306m-credit-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432161\" data-ts=\"1549983309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRNS\" target=\"_blank\">VRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432161-benchmark-downgrades-varonis-on-transition-visibility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Benchmark downgrades Varonis on transition visibility</a></h4><ul><li>Benchmark downgrades Varonis Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/VRNS' title='Varonis Systems Inc'>VRNS</a>) from Buy to Hold after yesterday's <a href=\"https://seekingalpha.com/news/3431875-varonis-minus-18-percent-downside-q1-fy19-outlook\" target=\"_blank\">earnings report</a>.</li><li>The firm cites the company's guidance coming well below analyst estimates due to the transition to a subscription model.</li><li>Benchmark says management's qualitative commentary on the shift was \"a bit murky\" with some investors questioning the timing, reasoning, and execution.</li><li>Benchmark expects Varonis to be a \"temporarily broken stock\" for the next two to three quarters with shares down in the low $50s range until the transition visibility improves.</li><li>VRNS shares are <font color=\"red\">down 19%</font> to $51.83.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432161\" data-linked=\"Benchmark downgrades Varonis on transition visibility\" data-tweet=\"$VRNS - Benchmark downgrades Varonis on transition visibility https://seekingalpha.com/news/3432161-benchmark-downgrades-varonis-on-transition-visibility?source=tweet\" data-url=\"https://seekingalpha.com/news/3432161-benchmark-downgrades-varonis-on-transition-visibility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432157\" data-ts=\"1549982758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAOI\" target=\"_blank\">AAOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432157-applied-optominus-4_1-rosenblatt-trims-target-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Opto -4.1% as Rosenblatt trims target again</a></h4><ul>   <li>Applied Optoelectronics (NASDAQ:<a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a>) is slipping out of today's open, <font color=\"red\">down 4.1%</font>, as Rosenblatt has cut its price target to a Street-low $10.</li>    <li>That implies 37% downside from yesterday's close.</li>    <li>The firm says Applied Opto has lost Facebook as a customer, a development Rosenblatt signaled when it <a href=\"https://seekingalpha.com/news/3404093-applied-opto-minus-4_8-percent-rosenblatt-slashes-targets\" target=\"_blank\">slashed its AAOI price target in half</a> in November, to $15.</li>    <li>AAOI was again seeing laser quality issues and wasn't expecting revenue from Facebook going forward, Rosenblatt said at the time.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432157\" data-linked=\"Applied Opto -4.1% as Rosenblatt trims target again\" data-tweet=\"$AAOI - Applied Opto -4.1% as Rosenblatt trims target again https://seekingalpha.com/news/3432157-applied-optominus-4_1-rosenblatt-trims-target-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3432157-applied-optominus-4_1-rosenblatt-trims-target-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432154\" data-ts=\"1549982728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRS\" target=\"_blank\">BRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432154-bristowminus-30-after-earnings-accounting-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristow -30% after earnings, accounting warning</a></h4><ul> <li>Bristow (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) is <font color=\"red\">down 30.4%</font> after <a href=\"https://seekingalpha.com/pr/17408485-bristow-group-reports-preliminary-third-quarter-fiscal-year-2019-results\" target=\"_blank\">reporting</a> preliminary earnings and disclosing a material weakness in its internal controls.</li> <li>The icing on the cake was that the company also announced that its agreement to acquire Columbia was terminated by mutual agreement of the parties.</li> <li>Evercore is quick to chip in, saying that it expects a \"turbulent\" ride for Bristow investors through 2020.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431894-bristow-group-reports-preliminary-q3-results-beats-0_51-misses-revenue\" target=\"_blank\">Bristow Group reports preliminary Q3 results; beats by $0.51, misses on revenue</a> (Feb. 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432154\" data-linked=\"Bristow -30% after earnings, accounting warning\" data-tweet=\"$BRS - Bristow -30% after earnings, accounting warning https://seekingalpha.com/news/3432154-bristowminus-30-after-earnings-accounting-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3432154-bristowminus-30-after-earnings-accounting-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432152\" data-ts=\"1549982351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADIL\" target=\"_blank\">ADIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432152-adial-pharma-readies-equity-offering-shares-down-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adial Pharma readies equity offering; shares down 11%</a></h4><ul><li>Adial Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ADIL' title='ADial Pharmaceuticals, Inc'>ADIL</a> <font color=\"red\">-10.5%</font>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1513525/000121390019002177/fs12019_adialpharma.htm\" target=\"_blank\">prospectus</a> for a public offering of 1,855,287 shares of common stock, each with an accompanying five-year warrant to purchase 3/4 of a share of common (total of 1,391,465 shares) at a combined price of $5.39.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432152\" data-linked=\"Adial Pharma readies equity offering; shares down 11%\" data-tweet=\"$ADIL - Adial Pharma readies equity offering; shares down 11% https://seekingalpha.com/news/3432152-adial-pharma-readies-equity-offering-shares-down-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3432152-adial-pharma-readies-equity-offering-shares-down-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432142\" data-ts=\"1549981718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432142-sellas-to-launch-study-of-gps-keytruda-in-wt1-cancers-shares-up-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SELLAS to launch study of GPS + Keytruda in WT1+ cancers; shares up 4% premarket</a></h4><ul><li>SELLAS Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a>) <a href=\"https://seekingalpha.com/pr/17409343-sellas-life-sciences-provides-galinpepimut-s-nelipepimut-s-program-update\" target=\"_blank\">updates </a>on two pipeline programs:</li><li>Galinpepimut-S &#40;GPS&#41;: An open-label 90-subject Phase 1/2 clinical trial evaluating GSP + Merck's (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) Keytruda (pembrolizumab) in patients with selected WT1-positive advanced cancers, both solid tumors and blood cancers, is set to launch.</li><li>NeuVax (nelipepimut-S): Preliminary data from a Phase 2b study assessing the combination of NeuVax and Roche's (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a>) Herceptin (trastuzumab) in patients with HER2 low-expressing breast cancer showed up to a 3x higher immune response compared to Herceptin alone in a subgroup of patients with triple-negative breast cancer.</li><li>Shares are up <font color=\"green\">4%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432142\" data-linked=\"SELLAS to launch study of GPS + Keytruda in WT1+ cancers; shares up 4% premarket\" data-tweet=\"$SLS $SLS $MRK - SELLAS to launch study of GPS + Keytruda in WT1+ cancers; shares up 4% premarket https://seekingalpha.com/news/3432142-sellas-to-launch-study-of-gps-keytruda-in-wt1-cancers-shares-up-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3432142-sellas-to-launch-study-of-gps-keytruda-in-wt1-cancers-shares-up-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432141\" data-ts=\"1549981640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTWO\" target=\"_blank\">TTWO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432141-take-twominus-2_6-bmo-breaks-bear-seal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Take-Two -2.6% as BMO breaks bear seal</a></h4><ul>   <li>While EA is <a href=\"https://seekingalpha.com/news/3432137-ea-plus-8_8-percent-analysts-praise-apex-legends-rocket-growth\" target=\"_blank\">flying high premarket</a>, videogame publisher Take-Two Interactive Software (NASDAQ:<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a>) is <font color=\"red\">2.6% lower</font> premarket after a downgrade to Underperform at BMO Capital Markets.</li>    <li>The firm cut its rating from Market Perform -- the first to depart from a heavily bullish chorus and rate TTWO Sell-equivalent.</li>    <li>Shares have <font color=\"red\">fallen 12%</font> over the past week and are <font color=\"red\">down 25.7%</font> over the past quarter.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3432141\" data-linked=\"Take-Two -2.6% as BMO breaks bear seal\" data-tweet=\"$TTWO - Take-Two -2.6% as BMO breaks bear seal https://seekingalpha.com/news/3432141-take-twominus-2_6-bmo-breaks-bear-seal?source=tweet\" data-url=\"https://seekingalpha.com/news/3432141-take-twominus-2_6-bmo-breaks-bear-seal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432139\" data-ts=\"1549981437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432139-ea-fro-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EA, FRO among premarket gainers</a></h4><ul><li>CAS Medical Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CASM' title='CAS Medical Systems, Inc.'>CASM</a>) <font color=\"green\">+54%</font> on being <a href=\"https://seekingalpha.com/news/3432108-edwards-lifesciences-acquire-cas-medical-systems-100m\" target=\"_blank\">acquired</a> by Edwards Lifesciences.</li><li>Ellie Mae (NYSEMKT:<a href='https://seekingalpha.com/symbol/ELLI' title='Ellie Mae, Inc.'>ELLI</a>) <font color=\"green\">+21%</font> on <a href=\"https://seekingalpha.com/news/3432075-ellie-mae-going-private-3_7b-deal\" target=\"_blank\">going private</a> in $3.7B deal.</li><li>Coty (NYSE:<a href='https://seekingalpha.com/symbol/COTY' title='Coty Inc.'>COTY</a>) <font color=\"green\">+17%</font> after JAB tender <a href=\"https://seekingalpha.com/news/3432037-coty-plus-14-percent-jab-tender-offer\" target=\"_blank\">offer.</a></li><li>Mimecast (NASDAQ:<a href='https://seekingalpha.com/symbol/MIME' title='Mimecast'>MIME</a>) <font color=\"green\">+13%</font> <a href=\"https://seekingalpha.com/news/3432052-mimecast-plus-8_6-percent-beat-raise-upgrade\" target=\"_blank\">after</a> beat-and-raise, upgrade.</li><li>Pyxus (NYSE:<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>) <font color=\"green\">+12%</font> on Q3 <a href=\"https://seekingalpha.com/news/3431887-pyxus-international-reports-q3-results\" target=\"_blank\">earnings</a>.</li><li>Chegg (NYSE:<a href='https://seekingalpha.com/symbol/CHGG' title='Chegg, Inc.'>CHGG</a>) <font color=\"green\">+10%</font> on Q4 <a href=\"https://seekingalpha.com/news/3431827-chegg-beats-0_04-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>ToughBuilt (NASDAQ:<a href='https://seekingalpha.com/symbol/TBLT' title='ToughBuilt Industries, Inc.'>TBLT</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/pr/17409528-toughbuilt-partners-wingpoint-group-launch-amazon-online-storefront-along-new-product\" target=\"_blank\">partnering</a> with WingPoint Group.</li><li>Frontline (NYSE:<a href='https://seekingalpha.com/symbol/FRO' title='Frontline Ltd.'>FRO</a>) <font color=\"green\">+10%</font>.</li><li>On Deck Capital (NYSE:<a href='https://seekingalpha.com/symbol/ONDK' title='OnDeck Capital'>ONDK</a>) <font color=\"green\">+9%</font> on Q4 <a href=\"https://seekingalpha.com/news/3432016-ondeck-capital-beats-0_04-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>ADMA Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics Inc'>ADMA</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3432085-adma-biologics-enters-72_5m-loan-facility-shares-7-percent-premarket\" target=\"_blank\">entering</a> into $72.5M loan facility.</li><li>Electronic Arts (NASDAQ:<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>) <font color=\"green\">+8%</font> as Apex Legends' <a href=\"https://seekingalpha.com/news/3431932-ea-plus-6_2-percent-apex-legends-crosses-25m-player-mark\" target=\"_blank\">crosses</a> 25M-player mark.</li><li>Viking Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a>) <font color=\"green\">+7%</font> as <a href=\"https://seekingalpha.com/news/3431928-viking-therapeutics-madrigal-move-gilead-liver-drug-fails-meet-goals\" target=\"_blank\">Gilead liver drug fails</a> to meet goals.</li><li>Kamada (NASDAQ:<a href='https://seekingalpha.com/symbol/KMDA' title='Kamada Ltd'>KMDA</a>) <font color=\"green\">+7%</font> on Q4 <a href=\"https://seekingalpha.com/news/3431981-kamada-beats-0_29-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>Conatus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3432063-conatus-completes-enrollment-mid-stage-study-emricasan-nash-cirrhosis\" target=\"_blank\">completing</a> enrollment in mid-stage study of emricasan in NASH cirrhosis.</li><li>RingCentral (NYSE:<a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>) <font color=\"green\">+6%</font> on Q4 <a href=\"https://seekingalpha.com/news/3431815-ringcentral-beats-0_05-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>Denbury Resources (NYSE:<a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a>) <font color=\"green\">+6%</font> after <a href=\"https://seekingalpha.com/news/3425080-denbury-resources-plus-3-percent-ruling-wyoming-helium-supply-contract-case\" target=\"_blank\">ruling</a> in Wyoming helium supply contract case.</li><li>Trevena (NASDAQ:<a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432139\" data-linked=\"EA, FRO among premarket gainers\" data-tweet=\"$CASM $ELLI $COTY - EA, FRO among premarket gainers https://seekingalpha.com/news/3432139-ea-fro-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3432139-ea-fro-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432137\" data-ts=\"1549981347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432137-eaplus-8_8-analysts-praise-apex-legends-rocket-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EA +8.8% as analysts praise &#39;Apex Legends&#39; rocket growth</a></h4><ul>   <li>Electronic Arts (NASDAQ:<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>) is <font color=\"green\">up 8.8%</font> premarket after last night's news that its silver lining from a disappointing earnings report may be a key contributor going forward.</li>    <li>The shares jumped early Monday and shed those gains before <a href=\"https://seekingalpha.com/news/3431932-ea-plus-6_2-percent-apex-legends-crosses-25m-player-mark\" target=\"_blank\">rising again postmarket</a> with the announcement that <i>Apex Legends,</i> its battle-royale answer to phenomenon <i>Fortnite,</i> had crossed 25M players in just a week of release.</li>    <li><i>Fortnite</i> took a little over 40 days to get to 20M users, and Bernstein observes that <i>Apex Legends</i> is growing faster than Activision's (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>) <i>Overwatch,</i> which too more than a year to 30M. Analyst Todd Juenger says EA's game is a \"stunning success\" that should ease pressure on management, and boosts his price target to $120 from $91, implying 23% upside.</li>    <li>Baird runs those numbers out and says EA could generate $500M in related revenue in 2020. Analyst Colin Sebastian writes: \"While there is still limited data on player retention and monetization, we believe this update from Respawn should provide investors with better visibility that <em>Apex</em> could be a meaningful hit for EA over the coming year.\" (h/t Bloomberg)</li>    <li>He's raised his price target to $106 from $90.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432137\" data-linked=\"EA +8.8% as analysts praise &#39;Apex Legends&#39; rocket growth\" data-tweet=\"$EA $ATVI - EA +8.8% as analysts praise &#39;Apex Legends&#39; rocket growth https://seekingalpha.com/news/3432137-eaplus-8_8-analysts-praise-apex-legends-rocket-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3432137-eaplus-8_8-analysts-praise-apex-legends-rocket-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432136\" data-ts=\"1549981323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGS\" target=\"_blank\">MDGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432136-medigus-nabs-patent-in-us-for-scoutcam-micro-visual-technology\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medigus nabs patent in US for ScoutCam Micro-Visual Technology</a></h4><ul> <li>Medigus (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd'>MDGS</a>) has <a href=\"https://seekingalpha.com/pr/17408998-medigus-announces-us-patent-micro-scoutcam-micro-visual-technology\" target=\"_blank\">received</a> a notice of allowance from USPTO for its innovative ScoutCam Micro-Visual Technology.</li>   <li>The U.S patent number is 10,188,275 and it is titled Small Diameter Video Camera Heads and Visualization Probes and Medical Devices Containing Them.</li><li>The patent is valid until March 16, 2031.</li><li>Shares are up <font color=\"green\">2%</font> premarket.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3432136\" data-linked=\"Medigus nabs patent in US for ScoutCam Micro-Visual Technology\" data-tweet=\"$MDGS - Medigus nabs patent in US for ScoutCam Micro-Visual Technology https://seekingalpha.com/news/3432136-medigus-nabs-patent-in-us-for-scoutcam-micro-visual-technology?source=tweet\" data-url=\"https://seekingalpha.com/news/3432136-medigus-nabs-patent-in-us-for-scoutcam-micro-visual-technology\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432132\" data-ts=\"1549981034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRIX\" target=\"_blank\">IRIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432132-iridex-resolves-dispute-quantel-medical\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IRIDEX resolves dispute with Quantel Medical</a></h4><ul> <li>IRIDEX (NASDAQ:<a href='https://seekingalpha.com/symbol/IRIX' title='IRIDEX Corporation'>IRIX</a>) has <a href=\"https://seekingalpha.com/pr/17409154-iridex-announces-resolution-dispute-quantel-medical\" target=\"_blank\">resolved</a> its differences with Quantel in its lawsuit filed against the latter in the U.S. District Court for the Northern District of California.</li><li>IRIDEX dismissed the lawsuit filed in January 2018, alleging that Quantel products infringed IRIDEX\u2019s U.S. Patent No. 7,771,417, that Quantel breached an earlier agreement between the parties, and infringed IRIDEX\u2019s MicroPulse U.S. Trademark.</li><li>IRIX shares are up <font color=\"green\">2%</font> premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3432132\" data-linked=\"IRIDEX resolves dispute with Quantel Medical\" data-tweet=\"$IRIX - IRIDEX resolves dispute with Quantel Medical https://seekingalpha.com/news/3432132-iridex-resolves-dispute-quantel-medical?source=tweet\" data-url=\"https://seekingalpha.com/news/3432132-iridex-resolves-dispute-quantel-medical\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432131\" data-ts=\"1549980825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432131-tap-shop-and-acb-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TAP, SHOP and ACB among premarket losers</a></h4><ul><li>Varonis Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/VRNS' title='Varonis Systems Inc'>VRNS</a>) <font color=\"red\">-24%</font> on <a href=\"https://seekingalpha.com/news/3431822-varonis-beats-0_20-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"red\">-23%</font> on <a href=\"https://seekingalpha.com/news/3431894-bristow-group-reports-preliminary-q3-results-beats-0_51-misses-revenue\" target=\"_blank\">preliminary Q3 results</a>.</li><li>PHI (NASDAQ:<a href='https://seekingalpha.com/symbol/PHIIK' title='PHI, Inc. - Non'>PHIIK</a>) <font color=\"red\">-9%</font>.</li><li>Molson Coors Brewing (NYSE:<a href='https://seekingalpha.com/symbol/TAP' title='Molson Coors Brewing Company'>TAP</a>) <font color=\"red\">-7%</font> on <a href=\"https://seekingalpha.com/news/3432009-molson-coors-brewing-beats-0_05-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Payment Data Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/PYDS' title='Payment Data Systems, Inc.'>PYDS</a>) <font color=\"red\">-7%</font> on <a href=\"https://seekingalpha.com/news/3432119-payment-data-systems-announces-2m-registered-direct-equity-offering-shares-7-percent\" target=\"_blank\">announcing</a> $2M registered direct offering.</li><li>Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify'>SHOP</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3432008-shopify-beats-0_05-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3431915-aurora-cannabis-reports-q2-results\" target=\"_blank\">Q2 earnings</a>.</li><li>IPG Photonics (NASDAQ:<a href='https://seekingalpha.com/symbol/IPGP' title='IPG Photonics Corporation'>IPGP</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3432068-ipg-photonics-misses-0_01-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432131\" data-linked=\"TAP, SHOP and ACB among premarket losers\" data-tweet=\"$VRNS $BRS $PHIIK - TAP, SHOP and ACB among premarket losers https://seekingalpha.com/news/3432131-tap-shop-and-acb-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3432131-tap-shop-and-acb-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432120\" data-ts=\"1549979977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UA\" target=\"_blank\">UA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432120-under-armour-tightens-up-on-costs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour tightens up on costs</a></h4><ul> <li>Investors give Under Armour (<a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc. Class C'>UA</a>, <a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc. Class C'>UA</a>) credit for tightening up in FQ2, pushing shares <font color=\"green\">up 2.2%</font> in premarket trading.</li> <li>Standing out was the UA's gross margin rate of 45.1% during the quarter that topped expectations and the 12% drop in inventory to the lowest level in almost two years.</li> <li>While the company's sales in North America and Latin America fell more than anticipated, the Europe business outperformed.</li> <li>\"As we look ahead to 2019, our accelerated innovation agenda, disciplined go-to-market process and powerful consumer-centric approach gives us increasingly greater confidence in our ability to deliver for Under Armour athletes, customers and shareholders,\" says CEO Kevin Plank.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432024-armour-plus-3-percent-earnings-beat\" target=\"_blank\">Under Armour +3% on earnings beat</a> (Feb. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432120\" data-linked=\"Under Armour tightens up on costs\" data-tweet=\"$UA - Under Armour tightens up on costs https://seekingalpha.com/news/3432120-under-armour-tightens-up-on-costs?source=tweet\" data-url=\"https://seekingalpha.com/news/3432120-under-armour-tightens-up-on-costs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432117\" data-ts=\"1549979964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNCA\" target=\"_blank\">GNCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432117-genocea-secures-15m-capital-raise-option-for-24m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genocea secures $15M capital raise, option for $24M more</a></h4><ul><li>Genocea Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GNCA' title='Genocea Biosciences, Inc.'>GNCA</a>) has <a href=\"https://seekingalpha.com/pr/17409284-genocea-announces-private-placement-financing-39-million\" target=\"_blank\">agreed to sell</a> up to $39.2M of stock and warrants to existing and new investors in a private transaction. Specifically, it will sell 25.6M common shares, each with an accompanying five-year warrant to purchase 1/4 of a share of common at $0.5656, plus 4.25M pre-funded warrants. Gross proceeds will be ~$15M. Closing date is February 14.</li><li>Contingent on successful results from its Phase 1/2a study of GEN-009, it will have the option to sell up to $24.2M of stock to the same investors at the greater of $0.4713 per share or the volume weighted average price between the release of the Phase 1/2a data and the company's exercise of the option.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432117\" data-linked=\"Genocea secures $15M capital raise, option for $24M more\" data-tweet=\"$GNCA - Genocea secures $15M capital raise, option for $24M more https://seekingalpha.com/news/3432117-genocea-secures-15m-capital-raise-option-for-24m?source=tweet\" data-url=\"https://seekingalpha.com/news/3432117-genocea-secures-15m-capital-raise-option-for-24m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432115\" data-ts=\"1549979834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JLL\" target=\"_blank\">JLL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432115-jones-lang-lasalleplus-3_2-after-q4-blow-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jones Lang LaSalle +3.2% after Q4 blow-out</a></h4><ul><li>Jones Lang LaSalle (NYSE:<a href='https://seekingalpha.com/symbol/JLL' title='Jones Lang Lasalle Inc.'>JLL</a>)<font color=\"green\"> gains 3.2</font>% in premarket trading after<a href=\"https://seekingalpha.com/pr/17408985-jll-reports-record-fourth-quarter-full-year-2018-results\" target=\"_blank\"> Q4 adjusted EPS</a> of $5.99 blows past the average analyst estimate of $4.89.</li><li>Compares with $4.53 a year ago.</li><li>\"We entered 2019 with strong business momentum that positions JLL for continued top-line and earnings growth in our Real Estate Services business,\" says JLL CEO Christian Ulbrich.</li><li>Q4 total revenue of $4.89B rose 13% from $4.34B in the year-ago quarter.</li><li>Q4 adjusted EBITDA of $418.0M vs. $330.8M a year ago; adjusted EBITDA margin, calculated on a fee-revenue basis, was 19.7% in U.S. dollars, compared with 17.7% in Q4 2017.</li><li>Assets under management were $60.5B as of Dec. 31, 2018, up 2% in U.S. dollars and local currency from $59.5B at Sept. 30, 2018.</li><li><a href=\"https://c212.net/c/link/?t=0&amp;l=en&amp;o=2370837-1&amp;h=1368644542&amp;u=https%3A%2F%2Fir.jll.com%2Foverview%2Fdefault.aspx&amp;a=ir.jll.com\" target=\"_blank\">Conference call</a> at 9:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432043-jones-lang-lasalle-beats-1_10-beats-revenue\" target=\"_blank\">Jones Lang Lasalle beats by $1.10, beats on revenue</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432115\" data-linked=\"Jones Lang LaSalle +3.2% after Q4 blow-out\" data-tweet=\"$JLL - Jones Lang LaSalle +3.2% after Q4 blow-out https://seekingalpha.com/news/3432115-jones-lang-lasalleplus-3_2-after-q4-blow-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3432115-jones-lang-lasalleplus-3_2-after-q4-blow-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432114\" data-ts=\"1549979759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHEK\" target=\"_blank\">CHEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432114-check-cap-up-5-on-receiving-irb-approval-for-pilot-study-of-c-scan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Check-Cap up 5% on receiving IRB approval for pilot study of C-Scan</a></h4><ul> <li>Check-Cap (NASDAQ:<a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a>) has <a href=\"https://seekingalpha.com/pr/17408925-check-cap-announces-institutional-review-board-approval-initiate-u-s-pilot-study-c-scan\" target=\"_blank\">received</a> Institutional Review Board &#40;IRB&#41; approval from New York University School of Medicine to initiate a U.S. pilot study of the C-Scan system.</li>                   <li>The U.S. pilot study will be a single-arm study enrolling up to 45 subjects considered to be of average risk for polyps and colon cancer. The study will evaluate the safety, usability, and subject compliance of the C-Scan system.</li><li>Shares are up <font color=\"green\">5%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3432114\" data-linked=\"Check-Cap up 5% on receiving IRB approval for pilot study of C-Scan\" data-tweet=\"$CHEK $CHEKZ $CHEK - Check-Cap up 5% on receiving IRB approval for pilot study of C-Scan https://seekingalpha.com/news/3432114-check-cap-up-5-on-receiving-irb-approval-for-pilot-study-of-c-scan?source=tweet\" data-url=\"https://seekingalpha.com/news/3432114-check-cap-up-5-on-receiving-irb-approval-for-pilot-study-of-c-scan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432113\" data-ts=\"1549979603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMY\" target=\"_blank\">HMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432113-harmony-goldplus-2-h1-profit-plunges-operational-cash-surges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harmony Gold +2% as H1 profit plunges, operational cash surges</a></h4><ul><li>Harmony Gold (NYSE:<a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a>) <font color=\"green\">+2.3%</font> pre-market after <a href=\"https://www.harmony.co.za/invest/reporting/fy19\" target=\"_blank\">H1 profit plunged 94%</a> Y/Y to 75M rand from 897M rand, but operations generated <a href=\"http://www.miningweekly.com/article/harmony-golds-net-profit-plunges-operational-cash-flow-soars-2019-02-12\" target=\"_blank\">1.1B rand in free cash flow</a> following the inclusion of the acquired Moab Khotsong mine in South Africa and the return to full production of the Hidden Valley mine in Papua New Guinea.</li><li>HMY <a href=\"https://seekingalpha.com/news/3431210-harmony-gold-warns-big-drop-h1-earnings\" target=\"_blank\">warned last week</a> of a big drop in H1 earnings, citing higher costs, a weaker rand and higher depreciation costs related to the Hidden Valley operations.</li><li>HMY says H1 gold production jumped 34% Y/Y to 751K oz. and that it is on track to achieve yearly production of 1.45M oz. of gold.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432113\" data-linked=\"Harmony Gold +2% as H1 profit plunges, operational cash surges\" data-tweet=\"$HMY - Harmony Gold +2% as H1 profit plunges, operational cash surges https://seekingalpha.com/news/3432113-harmony-goldplus-2-h1-profit-plunges-operational-cash-surges?source=tweet\" data-url=\"https://seekingalpha.com/news/3432113-harmony-goldplus-2-h1-profit-plunges-operational-cash-surges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432108\" data-ts=\"1549979236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EW\" target=\"_blank\">EW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432108-edwards-lifesciences-to-acquire-cas-medical-systems-for-100m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edwards Lifesciences to acquire CAS Medical Systems for $100M</a></h4><ul><li>Edwards Lifesciences (NYSE:<a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corporation'>EW</a>) has <a href=\"https://seekingalpha.com/pr/17409252-edwards-lifesciences-enters-agreement-acquire-casmed\" target=\"_blank\">agreed to acquire</a> CAS Medical Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CASM' title='CAS Medical Systems, Inc.'>CASM</a>) for $2.45 per share ($100M) in cash.</li><li>CAS has developed a <a href=\"http://www.fore-sight.com/products/adult/\" target=\"_blank\">cerebral oximetry device</a> used to monitor tissue oxygenation in the brain.</li><li>It closed yesterday at $1.57.</li><li><strong>Update</strong>: On April 18, EW <a href=\"https://seekingalpha.com/pr/17482011-edwards-lifesciences-completes-acquisition-casmed\" target=\"_blank\">announced</a> the completion of the transaction.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432108\" data-linked=\"Edwards Lifesciences to acquire CAS Medical Systems for $100M\" data-tweet=\"$EW $CASM - Edwards Lifesciences to acquire CAS Medical Systems for $100M https://seekingalpha.com/news/3432108-edwards-lifesciences-to-acquire-cas-medical-systems-for-100m?source=tweet\" data-url=\"https://seekingalpha.com/news/3432108-edwards-lifesciences-to-acquire-cas-medical-systems-for-100m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432096\" data-ts=\"1549978437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPGP\" target=\"_blank\">IPGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432096-ipg-photonicsminus-9-on-mixed-q4-downside-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IPG Photonics -9% on mixed Q4, downside outlook</a></h4><ul><li>IPG Photonics (NASDAQ:<a href='https://seekingalpha.com/symbol/IPGP' title='IPG Photonics Corporation'>IPGP</a>) <font color=\"red\">drops 8.9%</font> on trading resumption after reporting Q4 results that beat revenue estimates but missed on EPS.</li><li>Downside Q1 guidance has revenue from $290M to $320M (consensus: $324.12M) and EPS from $1.00 to $1.20 (consensus: $1.40).</li><li>Share repurchase: The IPGP board authorizes a new $125M anti-dilutive repurchase program.</li><li>Key management quote: \"While the global macroeconomic and geopolitical challenges affecting the sector and our business have persisted into 2019, we have seen some encouraging signs over the last two months. There has been a modest pickup in order activity since late December, and we are more encouraged by the overall demand environment than we were three months ago.\"</li><li>Earnings call is scheduled for 10 AM ET with a webcast available <a href=\"https://investor.ipgphotonics.com/overview/default.aspx\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17409164-ipg-photonics-announces-fourth-quarter-2018-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3432068-ipg-photonics-misses-0_01-beats-revenue\" target=\"_blank\">IPG Photonics misses by $0.01, beats on revenue</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3432096\" data-linked=\"IPG Photonics -9% on mixed Q4, downside outlook\" data-tweet=\"$IPGP - IPG Photonics -9% on mixed Q4, downside outlook https://seekingalpha.com/news/3432096-ipg-photonicsminus-9-on-mixed-q4-downside-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3432096-ipg-photonicsminus-9-on-mixed-q4-downside-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432095\" data-ts=\"1549978373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432095-teslas-charging-network-called-competitive-moat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla&#39;s charging network called a &#39;competitive moat&#39;</a></h4><ul> <li>Morgan Stanley <a href=\"https://www.cnbc.com/2019/02/12/morgan-stanley-tesla-charging-station-network-competitive-moat.html\" target=\"_blank\">calls</a> Tesla's (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) global network of 13K supercharger stations a \"competitive moat\" in comparison to other EV automakers.</li> <li>\"We estimate Tesla's chargers may account for 30 percent to 40 percent of total US charging outlets counted by the US Dept. of Energy,\" updates analyst Adam Jonas.</li> <li>\"Part of the strategic attraction to Tesla is its physical infrastructure footprint, which we believe, over time, can improve the customer experience, reduce friction points, and support the fleet management of many millions of Tesla vehicles on the road and in both captive and 3rd party commercial fleets,\" he adds.</li> <li>Tesla has a total of about 21K destination chargers, including its stations at hotels, malls and retail outlets.</li> <li>Shares of Tesla are <font color=\"green\">up 1.12%</font> in premarket trading to $316.34.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3432095\" data-linked=\"Tesla&#39;s charging network called a &#39;competitive moat&#39;\" data-tweet=\"$TSLA - Tesla&#39;s charging network called a &#39;competitive moat&#39; https://seekingalpha.com/news/3432095-teslas-charging-network-called-competitive-moat?source=tweet\" data-url=\"https://seekingalpha.com/news/3432095-teslas-charging-network-called-competitive-moat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>596&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432085\" data-ts=\"1549977982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMA\" target=\"_blank\">ADMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432085-adma-biologics-enters-72_5m-loan-facility-shares-up-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ADMA Biologics enters into $72.5M loan facility; shares up 7%  premarket</a></h4><ul><li>ADMA Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics Inc'>ADMA</a>) has <a href=\"https://seekingalpha.com/pr/17408993-adma-biologics-enters-72_5-million-loan-facility-perceptive-advisors\" target=\"_blank\">entered</a> into a senior secured term loan facility with Perceptive Advisors for up to $72.5M under two funding tranches.</li><li>The first tranche of $45M was used to prepay ADMA\u2019s former senior secured credit facility of $30M in full plus associated costs and fees.</li><li>The second loan facility tranche of $27.5M is predicated on FDA approval of either the BIVIGAM Prior Approval Supplement or the RI-002 BLA.</li><li>The Perceptive credit agreement has an interest only term with a maturity date of March 1, 2022. Borrowings bear interest at a rate per annum equal to 7.5% plus the greater of one-month LIBOR and 3.5%.</li><li>ADMA will also issue a warrant to Perceptive priced at a 115% premium to purchase 1,360,000 shares of the Company\u2019s common stock.</li><li>Shares are up <font color=\"green\">7%</font> premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3432085\" data-linked=\"ADMA Biologics enters into $72.5M loan facility; shares up 7%  premarket\" data-tweet=\"$ADMA - ADMA Biologics enters into $72.5M loan facility; shares up 7% premarket https://seekingalpha.com/news/3432085-adma-biologics-enters-72_5m-loan-facility-shares-up-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3432085-adma-biologics-enters-72_5m-loan-facility-shares-up-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3432084\" data-ts=\"1549977882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UUUU\" target=\"_blank\">UUUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3432084-energy-fuels-says-producing-vanadium-commercial-levels-sharesplus-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy Fuels says producing vanadium at commercial levels; shares +3%</a></h4><ul><li>Energy Fuels (NYSEMKT:<a href='https://seekingalpha.com/symbol/UUUU' title='Energy Fuels Inc'>UUUU</a>) <font color=\"green\">+3%</font> pre-market after announcing it is now <a href=\"https://seekingalpha.com/pr/17408813-energy-fuels-producing-vanadium-commercial-levels-vanadium-shipments-commenced\" target=\"_blank\">producing high-purity vanadium at commercial rates</a> of 175K-200K lbs./month of V<sub>2</sub>O<sub>5</sub> and that shipments of vanadium have commenced for sale to customers.</li><li>UUUU expects ramp-up to continue in the coming weeks, and the company says plans to reach full production rates of 200K-225K lbs./month of high-purity V<sub>2</sub>O<sub>5</sub> by the end of Q1 or sooner.</li><li>The company says vanadium markets have strengthened during 2019 following short-term softening observed in late December; the year-end 2018 mid-point spot price of V<sub>2</sub>O<sub>5</sub> in Europe was $15.50/lb. while the current reported price has climbed 11% to $17.25/lb.</li></ul><div class=\"tiny-share-widget\" data-id=\"3432084\" data-linked=\"Energy Fuels says producing vanadium at commercial levels; shares +3%\" data-tweet=\"$UUUU - Energy Fuels says producing vanadium at commercial levels; shares +3% https://seekingalpha.com/news/3432084-energy-fuels-says-producing-vanadium-commercial-levels-sharesplus-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3432084-energy-fuels-says-producing-vanadium-commercial-levels-sharesplus-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}